Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003245	s-c1inh	g/l (g/l)	1092	1295	0.08%
3003245	s-c1inh	— (—)	350	414	100.00%	Distribution not available
3003245	p-c1inh	g/l (g/l)	167	183	0.00%
3003245	p-c1inh	— (—)	27	32	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Urticaria and erythema

499

434

11.79

307.65

1.3

1.2

0.30

0.31

g/l

0.57

397

347

Oedema, not elsewhere classified

384

245

15.97

307.65

1.4

1.1

0.31

0.30

g/l

0.47

311

191

Adverse effects, not elsewhere classified

610

210

31.10

307.65

1.3

1.2

0.31

0.30

g/l

1.51

476

170

Other and unspecified urticaria

335

215

16.15

307.65

1.3

1.2

0.30

g/l

0.43

261

168

Other and unspecified effects of external causes

628

302

21.77

307.65

1.3

1.2

0.31

0.30

g/l

1.60

489

243

Urticaria

483

355

14.04

307.65

1.3

1.2

0.30

0.31

g/l

0.62

388

281

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

147

16.44

172.78

1.3

1.2

0.31

0.30

g/l

0.88

115

Other and unspecified drugs and medicaments

138

16.71

163.49

1.3

1.2

0.31

0.30

g/l

0.63

107

Oral corticosteroids

551

889

3.77

150.45

1.3

1.2

0.32

0.30

g/l

4.10

440

698

ILD medications: prednisolone, methylprednisolone, prednisone

540

856

3.58

134.10

1.2

0.31

0.30

g/l

2.25

439

662

Diseases of the skin and subcutaneous tissue

457

570

4.04

126.31

1.2

0.30

g/l

0.07

371

442

General symptoms and signs

513

702

3.68

125.93

1.3

1.2

0.30

g/l

0.12

412

549

ILD medications

539

879

3.38

122.06

1.2

0.31

0.30

g/l

2.27

439

681

Inflammatory bowel disease treatment related agents

543

934

3.32

121.11

1.3

1.2

0.32

0.30

g/l

4.18

432

735

First line medication for Crohn's disease

526

851

3.39

119.13

1.2

0.31

0.30

g/l

1.66

426

661

Dermatographic urticaria

13.34

102.77

1.2

0.30

0.29

g/l

0.48

Headache

304

652

3.92

98.11

1.3

1.2

0.30

g/l

0.31

236

509

Dermatitis and eczema

468

1096

2.81

83.66

1.2

0.31

0.30

g/l

0.14

383

855

Exposure to unspecified factor

426

1152

2.88

83.50

1.3

1.2

0.31

0.30

g/l

2.19

326

922

Asthma (only as main-diagnosis), excluding more controls

317

559

3.39

74.69

1.2

0.31

0.30

g/l

1.82

260

438

Asthma (only as main-diagnosis)

318

574

3.36

74.09

1.2

0.31

0.30

g/l

1.70

261

452

Pain in joint

259

457

3.77

73.54

1.3

1.2

0.31

g/l

0.00

211

359

Asthma (mode)

338

579

3.22

71.51

1.2

0.31

0.30

g/l

1.91

270

456

Other soft tissue disorders, not elsewhere classified

396

870

2.82

70.20

1.2

0.32

0.30

g/l

2.97

316

693

Asthma

339

574

3.18

69.82

1.2

0.31

0.30

g/l

1.82

274

452

Asthma, excluding more controls

335

559

3.21

69.73

1.2

0.31

0.30

g/l

2.19

270

438

Examination and observation for other reasons

248

402

3.77

68.25

1.2

0.31

g/l

0.13

217

311

Allergic rhinitis

162

378

4.28

62.03

1.2

0.30

g/l

0.30

126

312

Migraine

253

695

3.11

58.28

1.2

0.30

g/l

0.22

200

547

Immunodeficiencies

10.66

58.15

2.2

1.2

0.26

0.30

g/l

1.09

Abnormalities of breathing

362

821

2.63

55.79

1.3

1.2

0.31

0.30

g/l

1.23

275

649

Allergic urticaria

8.61

55.46

1.1

1.2

0.31

0.29

g/l

0.89

Complications of medical and surgical care

286

989

2.76

54.56

1.3

1.2

0.31

g/l

0.41

218

800

Malaise and fatigue

174

384

3.79

54.00

1.3

1.2

0.32

0.30

g/l

2.26

132

304

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

10.96

53.54

1.1

1.2

0.30

0.29

g/l

0.50

Pain in limb

310

836

2.69

52.90

1.3

1.2

0.32

0.30

g/l

3.13

248

664

Sequelae of other external causes

9.79

52.31

1.5

1.2

0.31

0.29

g/l

0.61

Pain in throat and chest

334

778

2.63

52.12

1.3

1.2

0.31

0.30

g/l

0.34

269

617

Unspecified privation

124

6.72

51.75

1.3

1.2

0.31

0.29

g/l

1.38

Pain, not elsewhere classified

119

261

4.59

50.13

1.2

0.31

0.30

g/l

0.96

205

Dermatitis

232

797

2.92

49.99

1.2

0.31

g/l

0.69

186

630

Other specific joint derangements/joint disorders

308

791

2.62

48.94

1.3

1.2

0.31

0.30

g/l

0.68

251

620

Other special examinations and investigations of persons without complaint or reported diagnosis

248

404

3.12

48.69

1.3

1.2

0.30

0.31

g/l

0.95

200

313

Asthma, hospital admissions , main diagnosis only

322

1204

2.40

45.92

1.2

0.31

0.30

g/l

1.25

264

948

Asthma and allergy

129

6.11

45.46

1.2

1.1

0.32

0.29

g/l

1.70

107

Medical observation and evaluation for suspected diseases and conditions

239

404

3.04

45.36

1.3

1.2

0.31

g/l

0.13

209

313

Asthma (diagnoses ohter than nonallergic)

331

1199

2.37

45.29

1.2

0.31

0.30

g/l

1.36

266

948

Other and unspecified dermatitis

200

669

3.00

45.28

1.2

0.31

0.30

g/l

0.52

162

535

190

616

3.08

44.72

1.2

0.31

0.30

g/l

0.38

154

488

Dorsalgia

374

870

2.34

44.15

1.3

1.2

0.31

0.30

g/l

0.14

299

686

Vasomotor and allergic rhinitis

181

572

3.14

43.95

1.2

0.30

g/l

0.00

144

453

Asthma, hospital admission 2, infections

224

800

2.77

43.49

1.2

0.31

0.30

g/l

0.57

184

640

Asthma-related infections

224

800

2.77

43.49

1.2

0.31

0.30

g/l

0.57

184

640

Anxiety disorders

353

1091

2.30

43.35

1.2

0.31

0.30

g/l

0.31

280

863

Asthma, unspecified (mode), excluding more controls

196

504

3.07

43.29

1.2

0.31

0.30

g/l

0.72

153

397

Sequelae of external causes of morbidity and mortality

115

278

4.17

42.86

1.3

1.2

0.33

0.30

g/l

2.68

219

Symptoms and signs involving the circulatory and respiratory systems

379

827

2.30

42.46

1.3

1.2

0.30

g/l

0.10

307

654

Neurotic, stress-related and somatoform disorders

349

1088

2.29

42.36

1.2

0.31

0.30

g/l

0.19

276

861

Asthma, unspecified (mode)

196

517

3.02

42.26

1.2

0.31

0.30

g/l

0.64

153

410

Asthma, including avohilmo

422

1144

2.15

41.95

1.2

0.31

0.30

g/l

0.93

339

904

Acute upper respiratory infections

370

1034

2.25

41.80

1.3

1.2

0.30

0.31

g/l

0.08

302

806

Opioids

373

866

2.27

40.94

1.3

1.2

0.31

0.30

g/l

1.21

294

684

Migraine with aura

134

383

3.53

39.39

1.2

0.30

g/l

0.07

106

311

Tramadol

285

751

2.45

39.16

1.3

1.2

0.32

0.30

g/l

2.78

233

597

Symptoms and signs involving the skin and subcutaneous tissue

256

1044

2.45

39.00

1.3

1.2

0.31

g/l

0.09

208

826

Dyspnoea

309

1037

2.29

38.30

1.3

1.2

0.31

0.30

g/l

0.95

239

836

Myalgia

110

282

3.93

37.90

1.4

1.2

0.31

0.30

g/l

1.26

221

Fever of other and unknown origin

169

524

3.00

37.67

1.3

1.2

0.31

0.30

g/l

0.88

140

417

Irritable bowel syndrome

133

392

3.42

37.30

1.2

0.30

g/l

0.06

105

309

Anxiety disorders, excluding more controls

318

938

2.26

36.79

1.3

1.2

0.31

0.30

g/l

0.87

256

746

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

187

661

2.78

36.76

1.3

1.2

0.31

g/l

0.04

143

520

Disturbances of skin sensation

132

393

3.38

36.46

1.3

1.2

0.30

0.29

g/l

0.37

102

308

Abdominal and pelvic pain

336

748

2.26

36.35

1.3

1.2

0.30

0.31

g/l

2.16

274

589

Other dorsopathies, not elsewhere classified

361

877

2.18

36.18

1.3

1.2

0.30

g/l

0.61

295

692

Acute upper respiratory infections of multiple and unspecified sites

277

892

2.33

35.76

1.3

1.2

0.31

0.30

g/l

0.18

225

689

Migraine with aura and triptan purchases

100

250

4.04

35.75

1.2

0.30

0.29

g/l

0.29

202

Chronic lower respiratory diseases

422

1128

2.03

35.62

1.2

0.31

0.30

g/l

1.30

330

895

Asthma and allergy, excluding more controls

163

4.83

35.31

1.2

1.1

0.32

0.29

g/l

1.90

130

Atopic dermatitis

227

779

2.50

34.92

1.3

1.2

0.30

g/l

0.12

183

607

Pollen allergy

115

319

3.60

34.79

1.2

0.29

g/l

0.09

259

383

972

2.09

34.57

1.3

1.2

0.31

0.30

g/l

0.10

311

757

Diarrhoea and gastroenteritis of presumed infectious origin

258

1013

2.32

34.34

1.3

1.2

0.30

g/l

0.05

212

810

Low back pain

257

841

2.36

34.28

1.3

1.2

0.31

0.30

g/l

0.13

207

663

Other/unspecified dorsalgia

145

474

3.06

33.99

1.3

1.2

0.30

0.31

g/l

0.23

115

379

Codeine

336

854

2.17

33.76

1.2

0.32

0.30

g/l

2.66

261

675

Symptoms and signs involving the digestive system and abdomen

329

748

2.21

33.68

1.3

1.2

0.29

0.31

g/l

2.68

267

589

Soft tissue disorders

359

887

2.11

33.13

1.2

0.31

0.30

g/l

1.69

288

704

Other headache syndromes

169

617

2.75

32.76

1.2

0.30

g/l

0.34

139

496

Certain disorders involving the immune mechanism

245

3.91

32.55

1.9

1.2

0.28

0.31

g/l

0.81

204

Cardiovascular diseases

264

610

2.37

32.31

1.2

0.30

0.29

g/l

0.76

216

476

Bronchitis

361

1174

2.02

31.77

1.3

1.2

0.31

0.30

g/l

0.25

291

922

Lower back pain or/and sciatica

347

1183

2.04

31.70

1.3

1.2

0.31

0.30

g/l

0.10

280

929

Allergic asthma (mode)

109

309

3.48

31.47

1.2

0.32

0.30

g/l

2.37

245

Allergic asthma (mode), excluding more controls

109

311

3.46

31.15

1.2

0.32

0.30

g/l

2.48

247

Symptoms and signs involving the nervous and musculoskeletal systems

202

826

2.45

31.06

1.2

0.31

0.30

g/l

0.78

159

666

Other diseases of intestines

371

1079

2.00

30.97

1.2

0.31

0.30

g/l

0.62

295

852

GASTRO-related operations

289

646

2.25

30.94

1.2

0.30

g/l

0.06

229

521

Any gastric operation

289

646

2.25

30.94

1.2

0.30

g/l

0.06

229

521

Other anxiety disorders

198

705

2.50

30.93

1.2

0.31

0.30

g/l

0.83

159

561

Atopic dermatitis, strict definition with reimbursement

137

445

3.00

30.92

1.2

0.30

g/l

0.32

110

354

General examination and investigation of persons without complaint and reported diagnosis

201

404

2.66

30.84

1.2

0.31

g/l

0.06

170

313

Biological medicines for asthma

15.84

30.74

1.4

1.1

0.31

0.29

g/l

0.31

Intestinal infectious diseases

318

1204

2.06

30.64

1.3

1.2

0.30

g/l

0.07

249

956

Anxiety (asthma-related co-morbidities)

246

853

2.28

30.60

1.2

0.31

0.30

g/l

0.43

199

675

Dorsopathies

354

889

2.04

29.87

1.3

1.2

0.30

g/l

0.61

283

700

Other diseases of upper respiratory tract

346

883

2.05

29.78

1.3

1.2

0.30

0.31

g/l

0.77

285

692

Other joint disorders

320

812

2.10

29.71

1.3

1.2

0.31

0.30

g/l

0.46

263

637

External causes of morbidity and mortality

221

445

2.49

29.50

1.3

1.2

0.30

g/l

0.11

171

363

Diseases of oesophagus, stomach and duodenum

351

1069

2.00

29.49

1.3

1.2

0.30

0.31

g/l

0.32

285

839

All anxiety disorders

247

893

2.23

29.39

1.2

0.31

0.30

g/l

0.42

200

701

Episodal and paroxysmal disorders

372

963

1.98

29.29

1.2

0.30

0.31

g/l

0.34

302

762

Arthropathies

330

812

2.07

29.15

1.3

1.2

0.30

g/l

0.35

265

637

Other external causes of accidental injury

276

628

2.21

28.29

1.3

1.2

0.30

g/l

0.06

214

505

Persons encountering health services for other counselling and medical advice, not elsewhere classified

358

1047

1.95

27.81

1.2

0.31

0.30

g/l

0.23

303

818

Abnormalities of heart beat

122

406

2.99

27.61

1.3

1.2

0.30

g/l

0.20

100

322

Neurological diseases, wide definition

130

201

3.26

27.49

1.2

0.29

0.28

g/l

0.30

104

149

Persons encountering health services in other circumstances, wide

385

1048

1.91

27.38

1.2

0.31

0.30

g/l

0.25

319

819

Codeine or tramadol medication

376

1091

1.91

27.31

1.2

0.32

0.30

g/l

2.67

290

870

Nerve, nerve root and plexus disorders

336

1076

1.97

27.23

1.2

0.31

g/l

0.16

268

848

Exposure to other specified factors

253

1130

2.11

26.84

1.2

0.31

0.30

g/l

0.91

211

897

Systemic connective tissue disorders

127

444

2.87

26.82

1.2

0.33

0.30

g/l

3.07

103

356

Parasetamol

283

680

2.13

26.81

1.3

1.2

0.30

g/l

0.53

218

541

Sciatica+with lumbago

170

654

2.48

26.50

1.2

0.31

g/l

0.05

135

519

Other pulmonary diagnosis

255

580

2.21

26.21

1.2

0.30

g/l

0.26

207

457

Dizziness and giddiness

237

893

2.16

26.12

1.3

1.2

0.31

g/l

0.84

184

715

Accidents

269

628

2.15

25.99

1.3

1.2

0.30

g/l

0.23

208

505

Certain infectious and parasitic diseases

334

849

1.97

25.88

1.2

0.31

0.30

g/l

1.84

262

677

Injury, poisoning and certain other consequences of external causes

174

332

2.63

25.87

1.3

1.1

0.29

0.30

g/l

0.69

138

265

Other complications of surgical and medical care, not elsewhere classified

111

5.01

25.80

1.2

0.31

0.29

g/l

1.08

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

121

187

3.25

25.59

1.2

0.28

0.31

g/l

2.97

142

Other systemic involvement of connective tissue (FG)

284

3.30

25.19

1.2

0.32

0.30

g/l

1.66

230

Other intervertebral disc disorders

261

763

2.10

25.11

1.2

0.30

0.31

g/l

0.45

215

601

Obesity related asthma

118

413

2.87

24.91

1.1

1.2

0.32

0.30

g/l

1.43

320

Infections of the skin and subcutaneous tissue

196

873

2.24

24.68

1.3

1.2

0.31

0.30

g/l

0.93

164

700

Gastro-oesophageal reflux disease

214

872

2.18

24.59

1.3

1.2

0.30

0.31

g/l

0.94

178

692

Asthma/COPD (KELA code 203)

308

1127

1.93

24.38

1.2

0.31

0.30

g/l

1.04

248

895

Hypertension, essential

247

662

2.13

24.35

1.2

0.32

0.30

g/l

5.12

196

528

Mood disorders, excluding more controls

310

971

1.95

24.33

1.3

1.2

0.31

0.30

g/l

1.40

249

771

Excluding asthma or asthma-COPD overlap

249

580

2.16

24.24

1.2

0.30

g/l

0.23

203

457

Chronic sinusitis

144

567

2.55

24.13

1.3

1.2

0.32

0.31

g/l

0.69

121

451

Other symptoms and signs involving the nervous and musculoskeletal systems

150

603

2.50

24.10

1.2

0.31

g/l

0.13

116

483

Fibromyalgia

110

4.87

24.09

1.4

1.2

0.32

0.29

g/l

1.41

Diseases of salivary glands

209

3.66

23.85

1.4

1.3

0.32

0.30

g/l

0.70

169

Triptan medication for migraine, single purchase ok

278

948

1.99

23.81

1.2

0.30

g/l

0.26

228

748

Migraine, single triptan purchase ok & required. ICD-code if available is included

278

948

1.99

23.81

1.2

0.30

g/l

0.26

228

748

Syncope and collapse

112

341

2.92

23.75

1.2

0.31

0.30

g/l

0.84

271

Acute sinusitis

184

762

2.26

23.30

1.2

0.31

0.30

g/l

0.77

150

596

Depression

316

1156

1.89

23.27

1.3

1.2

0.31

0.30

g/l

0.43

253

915

Mood disorders

332

1178

1.86

23.00

1.3

1.2

0.31

0.30

g/l

0.86

265

935

Mood [affective] disorders

331

1178

1.85

22.83

1.3

1.2

0.31

0.30

g/l

0.77

264

935

ILD differential diagnosis

244

579

2.12

22.73

1.2

0.30

g/l

0.13

197

456

Nausea and vomiting

260

3.27

22.64

1.2

0.32

0.31

g/l

0.48

205

COPD differential diagnosis

244

580

2.11

22.64

1.2

0.30

g/l

0.13

197

456

Rheumatism, unspecified

156

4.00

22.10

1.2

0.30

g/l

0.03

119

Recurrent or chronic depression

156

465

2.43

22.10

1.3

0.30

0.31

g/l

0.25

128

379

Antihypertensive medication - note that there are other indications

237

623

2.09

21.89

1.2

0.30

0.29

g/l

1.33

188

499

Depression medications

130

235

2.79

21.61

1.3

1.2

0.30

0.29

g/l

0.40

105

187

Cardiovascular diseases (excluding rheumatic etc)

249

712

2.03

21.58

1.2

0.31

0.29

g/l

1.65

200

564

Migraine without aura

333

2.93

21.30

1.2

0.29

0.30

g/l

0.32

271

Hypertensive diseases (excluding secondary)

192

501

2.23

21.30

1.2

0.33

0.30

g/l

4.22

157

394

Symptoms and signs involving cognition, perception, emotional state and behaviour

295

1108

1.87

21.29

1.3

1.2

0.31

0.30

g/l

1.24

235

882

Chronic rhinitis, nasopharyngitis and pharyngitis

112

417

2.70

21.11

1.2

0.32

0.31

g/l

0.56

333

Hypertensive diseases

247

696

2.01

20.98

1.2

0.33

0.30

g/l

5.55

197

556

Hypertension

247

696

2.01

20.97

1.2

0.33

0.30

g/l

5.55

197

556

Other functional intestinal disorders

138

541

2.44

20.93

1.3

1.2

0.31

0.30

g/l

0.68

102

436

COPD/asthma/ILD related infections

328

896

1.84

20.71

1.3

1.2

0.31

0.30

g/l

0.44

269

695

COPD/asthma related infections

328

896

1.84

20.71

1.3

1.2

0.31

0.30

g/l

0.44

269

695

Neurological diseases

285

748

1.92

20.65

1.2

0.30

g/l

0.30

231

589

Implicit Sepsis

205

768

2.08

20.47

1.3

1.2

0.32

0.30

g/l

1.74

169

612

Symptoms and signs involving speech and voice

110

415

2.66

20.23

1.2

0.31

g/l

0.25

329

Pain (limb, back, neck, head abdominally)

204

473

2.16

20.20

1.3

1.2

0.29

0.31

g/l

1.36

161

374

Diseases of the musculoskeletal system and connective tissue

189

426

2.23

20.09

1.3

1.2

0.29

g/l

0.08

152

342

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

294

1152

1.83

20.07

1.4

1.2

0.31

g/l

0.29

222

926

Anaemias

202

3.07

19.96

1.2

0.32

0.29

g/l

1.64

163

Vocal cord dysfunction

133

4.00

19.96

1.3

1.2

0.32

0.30

g/l

1.10

108

Other noninfective gastroenteritis and colitis

325

2.87

19.77

1.3

1.2

0.31

0.30

g/l

0.67

263

Somatoform disorder

222

3.31

19.72

1.3

1.2

0.31

0.30

g/l

0.39

182

Autoimmune diseases related-to ILD

262

1238

1.87

19.66

1.3

1.2

0.32

0.30

g/l

3.57

208

981

ILD medications: immunosuppressive drugs

168

744

2.17

19.55

1.2

0.32

0.30

g/l

3.08

137

584

Cervical disc disorders

109

419

2.61

19.33

1.2

0.30

0.31

g/l

0.51

335

Finngen Rheumatological endpoints

310

981

1.81

19.19

1.2

0.31

0.30

g/l

1.48

238

784

Chronic diseases of tonsils and adenoids

245

807

1.93

18.96

1.2

0.30

0.31

g/l

0.69

199

632

Other systemic involvement of connective tissue

344

2.77

18.95

1.2

0.33

0.30

g/l

1.85

274

Noninfective enteritis and colitis

155

704

2.21

18.91

1.3

1.2

0.31

0.30

g/l

0.55

119

565

Atopic dermatitis, strict definition

130

538

2.38

18.84

1.2

0.30

0.29

g/l

0.58

105

435

Cervicalgia

216

3.26

18.49

1.4

1.2

0.30

0.31

g/l

0.72

167

Lumbar disc prolapse

186

716

2.07

18.48

1.2

0.30

0.31

g/l

0.20

154

564

Diseases of the respiratory system

193

455

2.13

18.42

1.3

1.2

0.30

g/l

0.06

153

361

Viral Sepsis

197

3.37

18.38

1.5

1.2

0.33

0.30

g/l

1.46

159

Gastrointestinal diseases

203

489

2.08

18.37

1.3

1.2

0.29

0.30

g/l

1.07

163

380

Event of undetermined intent

5.00

18.30

1.1

1.2

0.33

0.29

g/l

1.72

Polyarthropathies

203

671

2.02

18.23

1.3

1.2

0.32

0.30

g/l

1.50

162

528

Any reimbursement code in KELA

220

549

2.01

18.17

1.2

0.30

0.29

g/l

1.59

186

427

Triptan medication for migraine, min. 3 purchases

215

874

1.95

18.02

1.2

0.30

g/l

0.74

172

693

Spondylosis

142

540

2.26

17.90

1.2

0.30

0.31

g/l

0.90

109

428

Sleep disorders (combined)

291

1072

1.78

17.89

1.2

0.31

g/l

0.48

225

857

Autoimmune diseases excluding thyroid diseases

314

993

1.76

17.76

1.2

0.32

0.30

g/l

3.54

251

791

Implicit viral Sepsis

197

3.32

17.69

1.5

1.2

0.33

0.30

g/l

1.45

159

Used for control exclusion in common control thyroid runs

322

933

1.75

17.63

1.2

0.31

0.30

g/l

0.83

258

740

Persons encountering health services for examination and investigation

175

404

2.18

17.62

1.2

0.29

0.31

g/l

1.47

140

313

Allergic contact dermatitis

164

3.56

17.58

1.1

1.2

0.30

g/l

0.16

127

Follow-up examination after treatment for conditions other than malignant neoplasms

125

336

2.44

17.57

1.1

1.2

0.32

0.31

g/l

0.86

266

Care involving use of rehabilitation procedures

194

936

1.97

17.50

1.2

0.32

0.31

g/l

1.36

157

747

Hypothyroidism, levothyroxine purchases

104

221

2.72

17.31

1.1

1.2

0.30

0.29

g/l

0.56

176

Hypothyroidism and >3 levothyroxin purchases

104

221

2.72

17.31

1.1

1.2

0.30

0.29

g/l

0.56

176

Migraine without aura and triptan purchases

275

2.89

17.03

1.3

1.2

0.29

g/l

0.16

223

Hypothyroidism (congenital or acquired)

104

223

2.69

17.00

1.1

1.2

0.30

0.29

g/l

0.47

178

Transport accidents

133

522

2.26

16.98

1.3

1.2

0.31

0.30

g/l

0.36

104

426

Spondylopathies

212

661

1.95

16.97

1.2

0.31

g/l

0.16

164

523

Non-invasive ventilation

217

3.09

16.95

1.2

0.31

0.30

g/l

0.23

177

Complications of surgical and medical care, not elsewhere classified

285

1168

1.75

16.91

1.2

0.32

0.30

g/l

1.52

217

931

Other arthritis (FG)

389

2.55

16.86

1.3

1.2

0.30

g/l

0.04

317

Supplementary factors related to causes of morbidity and mortality classified elsewhere

103

414

2.50

16.74

1.4

1.2

0.30

g/l

0.00

332

Undetermined asthma, excluding more controls

119

3.97

16.66

1.2

0.31

0.30

g/l

0.49

Undetermined asthma

119

3.97

16.66

1.2

0.31

0.30

g/l

0.24

Visual disturbances

141

651

2.17

16.65

1.2

0.31

0.30

g/l

0.21

106

527

Cystitis

267

913

1.79

16.49

1.3

1.2

0.30

g/l

0.08

210

726

Functional dyspepsia

336

2.66

16.45

1.1

1.2

0.30

0.31

g/l

0.19

267

Sleep apnoea, including avohilmo

273

1003

1.77

16.40

1.2

1.3

0.31

g/l

0.69

210

801

Other general symptoms and signs

5.92

16.28

1.2

1.1

0.31

0.29

g/l

0.66

Other specified/unspecified arthritis

318

2.68

16.00

1.3

1.2

0.30

g/l

0.05

249

Visual disturbances and blindness

145

689

2.11

15.93

1.2

0.31

0.30

g/l

0.32

110

559

Disorders of vestibular function (Vertigo)

126

566

2.22

15.66

1.2

0.31

g/l

0.18

460

Childhood asthma (age<16)

143

3.35

15.61

1.2

1.1

0.29

g/l

0.12

112

Persons encountering health services for specific procedures and health care

322

1197

1.67

15.59

1.2

0.31

0.30

g/l

1.23

255

947

Childhood asthma (age<16), excluding more controls

144

3.32

15.44

1.3

1.1

0.29

g/l

0.12

112

Disorders of conjunctiva

252

1206

1.75

15.43

1.2

0.31

0.30

g/l

0.27

210

946

Autoimmune diseases excluding thyroid diseases, strict definition

296

964

1.71

15.43

1.2

0.32

0.30

g/l

3.00

234

766

Pain and other conditions associated with female genital organs and menstrual cycle

343

2.56

15.42

1.3

1.2

0.29

0.30

g/l

0.21

274

Temporomandibular joint disorders

179

3.26

15.38

1.1

0.31

g/l

0.16

143

Concussion

147

612

2.08

15.24

1.3

1.2

0.31

0.30

g/l

0.21

109

484

Conjunctivitis

236

1160

1.78

15.24

1.2

0.31

0.30

g/l

0.31

195

909

Voice disturbances

345

2.56

15.12

1.3

1.2

0.31

g/l

0.23

271

Subjective visual disturbances

305

2.67

15.09

1.2

0.31

0.30

g/l

0.43

242

Non-allergic asthma (mode)

185

3.17

14.99

1.1

1.2

0.31

g/l

0.08

143

Other arrhythmias

193

782

1.89

14.94

1.3

1.2

0.30

0.31

g/l

0.29

153

623

Dislocation, sprain and strain of joints and ligaments at neck level

235

2.91

14.91

1.1

1.2

0.30

0.29

g/l

0.27

192

Non-allergic asthma (mode), excluding more controls

186

3.15

14.85

1.1

1.2

0.31

0.30

g/l

0.22

144

Stomatitis and related lesions

4.34

14.74

1.4

1.2

0.31

0.29

g/l

0.46

Sleep apnoea

249

965

1.75

14.70

1.2

0.31

g/l

0.52

193

767

Autoimmune diseases

325

1005

1.65

14.61

1.2

0.31

0.30

g/l

1.60

262

798

Diseases of pulp and periapical tissues

103

443

2.33

14.49

1.3

1.2

0.32

0.30

g/l

1.06

360

Other reaction to severe stress, and adjustment disorders

130

616

2.12

14.45

1.2

0.31

0.30

g/l

0.61

497

Cough

113

485

2.24

14.38

1.3

1.2

0.32

0.31

g/l

1.06

389

Hernia of abdominal wall, postoperative

167

3.25

14.30

1.3

1.2

0.30

0.31

g/l

0.12

142

Cardiac arrhythmias

202

721

1.86

14.29

1.3

1.2

0.31

0.30

g/l

1.56

157

576

Panic disorder

225

2.91

14.22

1.3

1.2

0.30

0.29

g/l

0.50

182

Diseases of the eye and adnexa

268

777

1.73

14.15

1.2

0.31

0.30

g/l

0.52

213

626

Rosacea

139

3.48

14.11

1.3

1.2

0.28

0.30

g/l

0.69

114

Dysphagia

206

2.97

13.94

1.3

1.2

0.31

0.32

g/l

0.42

164

Vasculitis limited to skin, not elsewhere classified

9.10

13.81

1.3

1.1

0.32

0.27

g/l

1.13

Inflammatory diseases of female pelvic organs

209

878

1.80

13.75

1.3

1.2

0.30

g/l

0.12

163

697

Intracranial trauma

164

631

1.95

13.75

1.3

1.2

0.31

0.30

g/l

0.18

125

497

Diaphragmatic hernia

393

2.37

13.64

1.3

1.2

0.33

0.30

g/l

3.09

309

Other and unspecified rosacea

105

3.84

13.59

1.3

1.2

0.28

0.29

g/l

0.39

Other heart diseases, wide

281

1051

1.66

13.47

1.3

1.2

0.31

0.30

g/l

1.44

221

839

Injuries to the neck

324

2.51

13.41

1.2

1.3

0.30

g/l

0.03

258

Pain in thoracic spine

164

3.19

13.37

1.3

1.2

0.30

0.31

g/l

0.27

130

Other diseases of lip and oral mucosa

149

3.30

13.36

1.2

1.3

0.30

g/l

0.24

121

Other disorders of teeth and supporting structures

217

2.87

13.31

1.3

0.31

0.30

g/l

0.32

172

Diseases of the ear and mastoid process

351

1125

1.58

13.23

1.2

0.30

0.31

g/l

0.40

277

895

Other diseases of urinary system

298

1026

1.64

13.22

1.2

0.30

0.31

g/l

0.20

239

818

Disorders of the thyroid gland

275

1088

1.65

13.14

1.2

0.31

0.30

g/l

0.67

224

860

Asthma-related pneumonia

369

2.39

13.11

1.3

1.2

0.32

0.30

g/l

0.76

286

Persons encountering health services in other circumstances

114

534

2.14

13.07

1.2

0.29

0.30

g/l

0.67

424

Shoulder lesions

198

668

1.82

12.98

1.3

1.2

0.31

0.30

g/l

0.54

162

530

Asthma-related pneumonia or sepsis

371

2.38

12.95

1.3

0.32

0.30

g/l

0.72

288

Asthma, hospital admissions 3, pneumonia

371

2.38

12.95

1.3

0.32

0.30

g/l

0.72

288

Chronic periapical parodontitis

215

2.85

12.94

1.2

1.3

0.34

0.30

g/l

2.68

172

Disorders of eyelid, lacrimal system and orbit

230

1056

1.71

12.90

1.3

1.2

0.30

0.31

g/l

0.16

173

857

Heartburn

3.98

12.88

1.1

1.2

0.30

0.31

g/l

0.31

Endometriosis of pelvic peritoneum

257

2.66

12.84

1.1

1.2

0.31

0.30

g/l

0.37

202

Other nutritional deficiencies

197

1095

1.76

12.70

1.2

0.32

0.30

g/l

2.49

156

864

Dental caries

294

2.54

12.68

1.3

1.2

0.31

0.30

g/l

0.23

235

Condition for Implicit Sepsis (Organ dysfunction codes)

224

947

1.72

12.66

1.3

1.2

0.32

0.30

g/l

1.98

185

756

Other symptoms and signs involving the circulatory and respiratory systems

4.78

12.59

1.1

1.2

0.30

g/l

0.10

Cutaneous abscess, furuncle and carbuncle

334

2.43

12.59

1.4

1.3

0.32

0.30

g/l

1.41

263

Acute bronchitis

111

512

2.13

12.56

1.3

1.2

0.32

0.30

g/l

0.75

411

Type of accident

379

2.33

12.42

1.4

1.3

0.30

g/l

0.00

301

Pruritus

112

3.59

12.40

1.2

1.3

0.32

0.30

g/l

1.01

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

436

2.23

12.39

1.3

1.2

0.30

g/l

0.11

345

Diseases of tongue

4.86

12.37

1.1

1.2

0.31

g/l

0.12

Other symptoms and signs involving the digestive system and abdomen

157

3.13

12.30

1.2

0.30

0.32

g/l

0.84

124

Other bacterial diseases

244

1011

1.67

12.29

1.2

0.33

0.30

g/l

5.06

196

808

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

176

963

1.80

12.25

1.2

0.31

0.30

g/l

0.35

143

757

Depression or dysthymia

197

614

1.80

12.25

1.3

1.2

0.29

0.31

g/l

1.76

159

496

Disorders of thyroid, IBD co-morbidities

147

2.94

12.24

1.1

1.2

0.31

0.29

g/l

1.46

112

Temporomandibular joint disorders, including avohilmo

149

789

1.89

12.15

1.2

0.30

g/l

0.06

117

631

Benign neoplasm: Colon

115

545

2.07

12.13

1.2

0.31

g/l

0.12

440

Other disorders of urethra and urinary system

197

841

1.76

12.10

1.2

0.31

0.30

g/l

0.42

157

674

Continuous positive airway pressure

143

3.09

12.05

1.1

1.2

0.32

0.31

g/l

0.76

122

Diseases of inner ear

136

686

1.95

12.04

1.2

0.31

g/l

0.30

103

555

Post-traumatic stress disorder

129

3.36

12.03

1.3

1.2

0.29

0.28

g/l

0.47

103

Complications of procedures, not elsewhere classified

218

1114

1.69

12.02

1.2

0.32

0.30

g/l

1.51

170

892

Allergic conjunctivitis

183

1022

1.77

11.95

1.2

0.31

0.30

g/l

0.23

150

807

Coxibs

169

2.56

11.93

1.2

0.29

0.30

g/l

0.63

136

Other antidepressants

286

927

1.61

11.82

1.3

1.2

0.31

0.30

g/l

0.22

233

730

Implicit bacterial Sepsis

348

2.30

11.73

1.3

1.2

0.33

0.31

g/l

1.59

273

Dentinal caries

256

2.57

11.56

1.4

1.3

0.30

g/l

0.01

203

Bacterial Sepsis

100

413

2.16

11.56

1.2

0.33

0.31

g/l

2.38

327

Hypothyroidism, other/unspecified

254

1033

1.63

11.44

1.1

1.2

0.31

0.30

g/l

0.88

199

820

Cervicobrachial syndrome

259

2.56

11.43

1.3

1.2

0.29

0.31

g/l

0.91

204

Rotator cuff syndrome

149

589

1.88

11.41

1.2

0.31

g/l

0.43

120

467

Other disorders of lacrimal gland

439

2.17

11.37

1.3

1.2

0.30

0.31

g/l

0.50

357

Disorders of lacrimal system

113

558

2.03

11.36

1.3

1.2

0.30

0.31

g/l

0.50

458

Acute pharyngitis

191

2.82

11.28

1.3

1.2

0.29

g/l

0.02

152

Dentofacial anomalies [including malocclusion]

398

2.22

11.22

1.2

0.31

0.30

g/l

0.41

318

Other disorders of patella

221

2.68

11.22

1.3

1.2

0.30

g/l

0.27

172

Brachial plexus disorders

130

3.25

11.20

1.1

0.30

0.29

g/l

0.50

109

Hypothyroidism, strict autoimmune

206

801

1.71

11.14

1.1

1.3

0.31

0.30

g/l

0.85

159

640

Bacterial infection, other or unspecified

119

542

1.98

11.05

1.2

0.34

0.30

g/l

4.60

437

Deviated nasal septum

361

2.28

11.03

1.3

1.2

0.29

0.31

g/l

1.67

286

Unspecified/other endometriosis

153

3.03

10.90

1.2

0.31

0.29

g/l

0.71

123

Other acute lower respiratory infections

142

733

1.85

10.85

1.2

0.31

0.30

g/l

0.41

114

588

Benign neoplasm of colon, rectum, anus and anal canal

133

634

1.90

10.84

1.2

0.31

g/l

0.24

104

513

Endocrine, nutritional and metabolic diseases

250

782

1.63

10.77

1.2

0.31

0.29

g/l

1.93

201

618

Obesity

183

1062

1.71

10.74

1.1

1.2

0.32

0.30

g/l

2.80

147

839

Other and unspecified tonsillitis

109

456

2.03

10.71

1.3

1.2

0.30

g/l

0.07

359

Endometriosis

124

371

1.99

10.70

1.1

1.2

0.30

g/l

0.08

297

All influenza

304

2.38

10.69

1.2

0.31

0.30

g/l

0.41

243

Ovarian cyst

131

388

1.96

10.67

1.3

1.2

0.30

g/l

0.00

103

308

Obesity and other hyperalimentation

183

1065

1.70

10.60

1.1

1.2

0.32

0.30

g/l

2.82

147

842

Injuries to the ankle and foot

206

1137

1.65

10.53

1.2

0.31

0.30

g/l

1.23

168

894

Atypical facial pain

4.66

10.48

1.5

1.1

0.30

0.29

g/l

0.37

Hypothyreosis and Thyroxine purchase for inclusion criteria

259

1083

1.58

10.45

1.2

0.31

0.30

g/l

0.72

203

864

Procreative management

105

435

2.04

10.44

1.4

1.2

0.29

0.30

g/l

0.97

350

Tongue abnormality

4.30

10.30

1.2

1.1

0.31

0.30

g/l

0.55

Abnormal involuntary movements

148

2.99

10.24

1.2

0.34

0.30

g/l

2.26

118

Erysipelas

123

590

1.91

10.22

1.3

1.2

0.33

0.30

g/l

1.83

476

Benign neoplasm: Colon

115

448

1.97

10.20

1.2

0.31

g/l

0.05

367

Other heart diseases

142

507

1.85

10.19

1.3

1.2

0.32

0.30

g/l

2.41

111

403

Convulsions, not elsewhere classified

212

2.62

10.18

1.4

1.2

0.28

0.30

g/l

0.84

169

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

143

733

1.81

10.15

1.3

1.2

0.33

0.31

g/l

2.46

114

590

Enthesopathies of lower limb, excluding foot

263

2.44

10.11

1.2

0.31

g/l

0.04

208

Trochanteric bursitis

139

3.04

10.05

1.3

1.2

0.29

0.30

g/l

0.39

107

Exposure to other and unspecified forces of nature

17.93

10.05

1.4

1.1

0.31

0.28

g/l

—

Other disorders of bone

283

2.38

9.98

1.3

1.2

0.30

g/l

0.06

226

Other arthrosis

121

450

1.93

9.93

1.2

0.32

0.31

g/l

0.21

101

357

Rash and other nonspecific skin eruption

115

3.24

9.84

1.0

1.3

0.31

0.30

g/l

0.32

Other noninfective disorders of lymphatic vessels and lymph nodes

4.95

9.80

1.1

0.31

0.29

g/l

0.25

Hypermobility syndrome

3.55

9.78

1.1

1.2

0.32

0.28

g/l

1.53

Disorders of skin appendages

143

805

1.78

9.71

1.2

0.29

0.30

g/l

0.69

106

657

STROKE

140

535

1.82

9.59

1.3

1.2

0.32

0.31

g/l

0.61

117

434

Diseases of oral cavity, salivary glands and jaws

235

753

1.60

9.58

1.2

0.31

0.30

g/l

0.13

187

601

Cervicocranial syndrome

112

3.23

9.56

1.2

0.29

0.31

g/l

1.16

Disorders of synovium and tendon

137

686

1.80

9.56

1.2

0.32

0.30

g/l

1.36

107

546

Heart failure, not strict

169

679

1.72

9.56

1.2

0.33

0.31

g/l

3.67

139

549

Enlarged lymph nodes

138

2.98

9.54

1.6

1.2

0.32

0.30

g/l

0.97

109

Sequelae with surgical and medical care as external cause

211

2.57

9.51

1.2

0.35

0.30

g/l

3.73

167

Injuries to the wrist and hand

270

1287

1.52

9.45

1.2

0.30

0.31

g/l

0.21

221

1009

Irregular menses

166

793

1.70

9.35

1.3

1.2

0.30

g/l

0.07

124

629

Endometriosis ASRM stages 1,2

317

2.25

9.34

1.1

1.2

0.31

0.30

g/l

0.37

257

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.43

9.32

1.3

1.2

0.34

0.29

g/l

2.53

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

135

468

1.83

9.32

1.3

1.2

0.30

g/l

0.09

115

371

Benzodiazepine use

264

1234

1.52

9.28

1.2

0.32

0.30

g/l

2.88

210

977

Oxycodone

350

2.16

9.27

1.3

1.2

0.33

0.30

g/l

1.79

288

Factors influencing health status and contact with health services

148

2.41

9.24

1.2

0.29

0.30

g/l

1.11

115

Benign neoplasm of colon, rectum, anus and anal canal

129

503

1.84

9.18

1.2

0.31

g/l

0.25

102

413

Falls/tendency to fall

320

1083

1.48

9.16

1.2

0.31

0.30

g/l

0.24

259

845

Metabolic disorders

236

937

1.57

9.14

1.2

0.33

0.30

g/l

4.72

189

745

Gout

189

2.56

9.14

1.1

1.3

0.34

0.31

g/l

1.25

152

Early onset COPD, excluding more controls

175

2.69

9.10

1.1

1.2

0.35

0.30

g/l

2.28

137

Cerebrovascular diseases (FINNGEN)

278

2.14

9.09

1.3

1.2

0.33

0.30

g/l

1.51

232

Other disorders of skin and subcutaneous tissue

163

888

1.68

9.04

1.2

0.32

0.31

g/l

2.36

127

714

Other neurological diseases

164

781

1.69

9.03

1.2

0.31

g/l

0.05

140

621

Any mental disorder

295

987

1.50

8.94

1.2

0.31

0.30

g/l

0.62

232

786

Arthrosis

175

571

1.69

8.87

1.2

0.31

g/l

0.11

140

444

Inflammatory disease of uterus

237

2.42

8.85

1.5

1.2

0.30

0.29

g/l

0.23

193

Psychiatric diseases

292

980

1.49

8.74

1.2

0.31

0.30

g/l

0.45

231

779

Cholecystectomy

175

945

1.64

8.73

1.2

0.32

0.31

g/l

1.26

136

757

Localized swelling, mass and lump of skin and subcutaneous tissue

379

2.09

8.71

1.4

1.2

0.30

g/l

0.04

300

Chronic laryngitis and laryngotracheitis

135

2.90

8.68

1.3

1.2

0.33

0.30

g/l

0.95

107

Infections, IBD-co-morbidities

102

2.94

8.62

1.2

1.3

0.31

0.28

g/l

0.85

Other shoulder lesions

104

3.19

8.62

1.5

1.2

0.30

0.29

g/l

0.14

Abnormal findings on diagnostic imaging of lung

477

1.94

8.54

1.3

1.2

0.33

0.31

g/l

1.43

387

Benign neoplasms

272

1013

1.50

8.53

1.2

0.31

0.30

g/l

0.52

213

811

Noninfectious colitis NAS

159

2.72

8.48

1.3

1.2

0.32

0.30

g/l

0.75

131

Carpal tunnel syndrome

150

803

1.69

8.42

1.2

0.30

0.31

g/l

1.44

125

640

Collagenous colitis

106

3.13

8.36

1.4

1.2

0.33

0.29

g/l

1.40

Papulosquamous disorders

100

530

1.89

8.34

1.3

1.2

0.31

g/l

0.02

423

Other symptoms and signs involving cognitive functions and awareness

430

1.97

8.34

1.3

0.31

g/l

0.14

351

Constipation

213

981

1.56

8.30

1.2

0.32

0.31

g/l

0.95

168

791

Hypothyroidism, drug reimbursement

131

2.63

8.24

1.1

1.2

0.30

0.29

g/l

0.25

104

Other and unspecified nerve root and plexus disorders, also in other diseases

233

2.37

8.21

1.1

1.2

0.31

0.30

g/l

0.43

187

Viral infections characterized by skin and mucous membrane lesions

110

604

1.82

8.19

1.4

1.2

0.32

0.30

g/l

1.09

485

Selective serotonin reuptake inhibitors

266

936

1.50

8.19

1.2

0.31

0.30

g/l

0.42

216

738

174

2.60

8.15

1.3

1.2

0.31

0.30

g/l

0.30

141

Persistent mood disorders

240

2.34

8.15

1.1

1.2

0.32

0.30

g/l

1.17

195

Codes for special purposes

127

730

1.74

8.13

1.2

0.31

0.30

g/l

0.41

592

Other gastritis (incl. Duodenitis)

228

2.38

8.12

1.1

1.2

0.32

0.31

g/l

0.26

179

Other specified/unspecified systemic involvement of connective tissue

3.65

8.01

1.3

1.1

0.30

0.29

g/l

0.26

Crohn disease

176

2.57

7.98

1.4

1.2

0.31

0.29

g/l

0.72

146

Intracranial injury

140

803

1.69

7.94

1.3

1.2

0.31

0.30

g/l

0.34

112

648

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

140

829

1.69

7.94

1.2

0.31

g/l

0.27

102

678

Excessive vomiting in pregnancy

148

2.72

7.92

1.2

0.29

g/l

0.05

121

Cellulitis

256

2.27

7.90

1.4

1.3

0.33

0.29

g/l

2.84

199

Provisional assignment of new diseases of uncertain etiology

126

729

1.73

7.90

1.2

0.31

0.30

g/l

0.48

591

Other disorders of eye and adnexa

189

2.50

7.87

1.1

1.2

0.31

0.30

g/l

0.46

154

Internal derangement of knee

491

1.89

7.81

1.2

0.32

0.30

g/l

0.74

382

Other condition

184

2.51

7.80

1.6

1.2

0.29

0.30

g/l

0.01

147

D07AA Corticosteroids, weak (group I)

227

2.34

7.73

1.1

1.2

0.32

0.29

g/l

1.47

184

Deforming dorsopathies

330

2.10

7.72

1.2

0.30

0.31

g/l

0.40

263

Other peripheral vertigo

101

3.09

7.70

1.2

0.31

0.30

g/l

0.32

Gout, FINNGEN

228

2.33

7.67

1.1

1.3

0.34

0.30

g/l

2.09

183

Chondropathies

210

2.39

7.64

1.2

0.30

0.29

g/l

0.46

169

Ocular pain

107

3.01

7.61

1.1

1.2

0.31

0.29

g/l

0.77

Other disorders of fluid, electrolyte and acid-base balance

289

2.14

7.52

1.1

1.3

0.33

0.31

g/l

2.22

230

Symptoms and signs concerning food and fluid intake

3.30

7.49

1.3

1.2

0.30

g/l

0.11

Adenomyosis (Endometriosis of uterus)

170

2.54

7.48

1.2

0.32

0.30

g/l

0.79

136

Obesity due to excess calories

131

780

1.68

7.43

1.1

1.2

0.32

0.30

g/l

3.06

109

629

Haemorrhage from respiratory passages

285

2.12

7.41

1.2

0.31

g/l

0.01

228

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

323

2.08

7.37

1.3

1.2

0.33

0.30

g/l

1.04

256

Hernia

225

1020

1.50

7.35

1.2

0.32

0.30

g/l

2.94

178

813

Glucagon-like peptide-1 (GLP-1) analogues

108

499

1.78

7.30

1.2

0.33

0.31

g/l

1.89

402

Abnormal findings on examination of blood, without diagnosis

505

1.82

7.23

1.2

0.34

0.30

g/l

2.86

407

Superficial injury of lower leg

333

2.05

7.18

1.3

1.2

0.31

0.30

g/l

0.98

264

Radiculopathy

150

2.61

7.18

1.4

1.2

0.32

g/l

0.04

118

Other diseases of hard tissues of teeth

158

734

1.61

7.17

1.2

0.30

g/l

0.13

124

585

Recurring oral aphthae, including avohilmo

168

2.51

7.15

1.6

1.3

0.30

g/l

0.02

136

Benign paroxysmal vertigo

327

2.05

7.14

1.2

1.3

0.30

0.31

g/l

0.42

262

Fall on same level

311

1236

1.41

7.09

1.3

1.2

0.31

0.30

g/l

0.84

255

964

Obesity, other/unspecified

553

1.79

7.06

1.1

1.2

0.33

0.30

g/l

2.96

445

Benign neoplasm: Colon, unspecified

218

2.30

7.05

1.2

0.30

0.31

g/l

0.56

172

Insulin, intermediate and long-acting

119

687

1.70

7.04

1.1

1.2

0.34

0.30

g/l

4.19

556

Benign neoplasm: Colon, unspecified

217

2.30

7.04

1.2

1.3

0.30

0.32

g/l

0.81

177

Osteopathies and chondropathies

128

728

1.67

7.03

1.2

0.31

0.30

g/l

0.34

103

593

Dental operations

150

467

1.65

7.01

1.2

0.29

0.31

g/l

2.05

115

380

Acetic acid derivatives and related substances

166

2.14

6.95

1.2

0.28

0.30

g/l

1.35

133

Hernia of abdominal wall

104

593

1.76

6.93

1.2

0.31

g/l

0.15

477

Venous thromboembolism

114

647

1.71

6.91

1.3

1.2

0.33

0.31

g/l

2.14

100

518

Injuries to the thorax

543

1.79

6.87

1.2

0.32

0.30

g/l

1.61

435

Injuries to the abdomen, lower back, lumbar spine and pelvis

490

1.83

6.83

1.2

1.3

0.31

0.30

g/l

0.05

388

Injuries to the knee and lower leg

307

1259

1.40

6.77

1.2

0.31

0.30

g/l

1.42

241

996

Diseases of external ear

431

1.88

6.76

1.2

0.30

g/l

0.12

345

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

112

656

1.71

6.76

1.2

0.31

0.30

g/l

0.91

521

Gout, idiopatic and unspecified

185

2.38

6.75

1.1

1.3

0.33

0.30

g/l

1.40

145

Genitourinary diseases

156

484

1.62

6.74

1.3

1.2

0.29

0.30

g/l

1.31

123

380

Correction of physiology of bite - demanding therapy visit

104

2.90

6.74

1.3

1.1

0.31

0.29

g/l

0.61

Unspecified fall

113

660

1.70

6.72

1.2

0.31

0.30

g/l

0.11

535

Other diseases of liver

217

2.27

6.69

1.1

1.2

0.32

0.31

g/l

0.43

173

Special screening examination for infectious and parasitic diseases

241

2.05

6.67

1.2

0.29

0.30

g/l

0.49

187

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.00

6.65

1.5

1.2

0.31

0.29

g/l

0.49

Nontoxic goitre/thyroid nodule

357

1.97

6.64

1.3

1.2

0.31

g/l

0.15

285

Gingivitis and periodontal diseases

216

749

1.49

6.58

1.2

0.31

0.30

g/l

0.50

172

597

Hypothyroidism, strict autoimmune, 3 medication purchases required

219

1018

1.47

6.56

1.2

0.31

0.30

g/l

0.38

167

809

Polycystic ovarian syndrome, consortium definition

215

877

1.48

6.56

1.3

1.2

0.30

g/l

0.19

163

702

Intestinal adhesions without obstruction

3.26

6.55

1.3

1.2

0.32

0.30

g/l

0.55

Other congenital malformations

134

2.63

6.53

1.1

1.2

0.28

0.29

g/l

0.03

109

Disorders of gallbladder, biliary tract and pancreas

237

1057

1.45

6.50

1.3

1.2

0.32

0.31

g/l

1.33

187

837

Mixed connective tissue disease

3.08

6.46

1.3

1.2

0.30

0.29

g/l

0.20

Spinal stenosis

412

1.79

6.44

1.1

1.3

0.31

g/l

0.23

327

KRA_PSY_EATING, excluding more controls

141

2.56

6.39

1.1

0.31

0.28

g/l

1.47

114

Exclusions for E4_PCOS_BROAD

241

2.16

6.37

1.3

1.2

0.33

0.30

g/l

1.58

196

Sulfasalazine

328

1.99

6.37

1.2

0.32

0.30

g/l

1.70

258

L04AA Selective immunosuppressants

301

2.03

6.36

1.2

0.33

0.30

g/l

2.77

240

Soft tissue disorders related to use, overuse and pressure

295

2.04

6.32

1.2

0.30

g/l

0.12

227

Type 2 diabetes, wide definition

170

721

1.54

6.32

1.2

0.33

0.31

g/l

2.66

127

576

Gonarthrosis

138

488

1.62

6.27

1.1

1.2

0.31

g/l

0.12

114

383

Other viral diseases, not elsewhere classified

275

2.07

6.27

1.2

0.32

0.29

g/l

2.26

227

Covid-19 confirmed case

379

1.90

6.25

1.2

1.3

0.32

0.30

g/l

1.15

309

Other and unspecified iron deficiency

393

1.89

6.24

1.2

0.31

0.30

g/l

0.35

319

Behavioural syndromes associated with physiological disturbances and physical factors

567

1.73

6.24

1.3

1.2

0.30

g/l

0.43

457

All influenza (not pneumonia)

186

2.32

6.22

1.2

0.30

g/l

0.02

149

Chronic kidney disease

236

2.16

6.21

1.1

1.2

0.37

0.31

g/l

4.33

188

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

230

1041

1.44

6.20

1.2

0.31

g/l

0.22

191

821

Benign neoplasms

225

877

1.45

6.19

1.2

0.31

0.30

g/l

0.39

178

707

Secondary hypertension

3.14

6.18

1.1

1.3

0.32

0.29

g/l

0.64

Noninflammatory disorders of female genital tract

137

423

1.63

6.17

1.3

1.2

0.29

0.30

g/l

0.52

104

338

Non-selective monoamine reuptake inhibitors

473

1.79

6.16

1.1

1.2

0.31

g/l

0.42

383

Crohn disease (strict definition, require KELA)

2.97

6.11

1.5

1.2

0.31

0.29

g/l

0.50

L04AD Calcineurin inhibitors

133

2.57

6.11

1.1

1.2

0.33

0.29

g/l

1.52

107

Diverticular disease of intestine

145

610

1.58

6.10

1.3

1.2

0.32

0.31

g/l

0.72

115

486

Excessive, frequent and irregular menstruation

122

408

1.67

6.09

1.3

1.2

0.29

0.30

g/l

0.25

326

Gout, unspecified

157

2.43

6.09

1.1

1.3

0.33

0.30

g/l

1.21

122

Other enthesopathies

404

1.86

6.08

1.2

0.29

0.30

g/l

0.49

317

COPD, hospital admission 2, with asthma infections

230

2.08

6.07

1.2

0.34

0.31

g/l

1.87

179

Inflammatory bowel disease

491

1.78

6.06

1.3

1.2

0.32

0.30

g/l

1.03

396

Nutritional anaemias

102

585

1.70

6.06

1.2

0.32

0.31

g/l

0.75

475

Polyarthrosis

168

2.35

6.05

1.3

1.2

0.29

0.32

g/l

1.60

132

Other skin changes

170

2.36

6.03

1.2

0.31

0.30

g/l

0.25

134

Nonorganic sleeping disorders, excluding more controls

247

2.11

6.02

1.3

1.2

0.30

0.29

g/l

0.20

199

Polyneuropathies and other disorders of the peripheral nervous system

208

2.22

6.01

1.1

1.2

0.31

g/l

0.36

163

Disorders of other endocrine glands

107

632

1.67

5.97

1.3

1.2

0.32

0.30

g/l

1.56

506

TMD related operations

249

2.10

5.90

1.2

0.32

0.30

g/l

0.98

203

Sequelae of injuries, of poisoning and of other consequences of external causes

317

1.96

5.89

1.2

0.32

0.30

g/l

0.92

253

Neuralgia and neuritis, unspecified

3.41

5.86

1.2

0.32

0.29

g/l

1.08

Crohn's disease of small intestine

2.96

5.84

1.6

1.2

0.32

0.29

g/l

0.82

Algoneurodystrophy

3.82

5.82

1.4

1.1

0.28

0.29

g/l

0.23

Dental caries 2 and operation codes

206

1136

1.44

5.82

1.2

0.30

g/l

0.92

166

889

Use of hypnotics and sedatives

264

1097

1.39

5.82

1.2

0.32

0.30

g/l

2.06

202

872

Insulin medication

128

690

1.59

5.76

1.1

1.2

0.34

0.30

g/l

4.32

549

Insulin, combination of fast acting with intermediate-acting or long-acting

128

747

1.58

5.73

1.1

1.2

0.34

0.30

g/l

4.32

598

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

131

836

1.57

5.72

1.2

0.31

g/l

0.34

679

Cluster headache, wide

3.93

5.72

1.1

0.29

g/l

0.01

Other inflammation of eyelid

144

2.44

5.68

1.3

1.2

0.30

0.31

g/l

0.08

117

Blepharochalasis

280

2.00

5.67

1.3

1.2

0.30

0.32

g/l

0.76

229

Preparation and fitting of bite rail to mouth

201

2.20

5.64

1.2

0.31

0.30

g/l

0.56

164

Dental caries 2

208

1144

1.43

5.63

1.2

0.30

g/l

0.52

167

895

Tonsillectomy and adenotomy

177

834

1.48

5.61

1.3

1.2

0.29

0.30

g/l

0.91

137

663

Impetigo

3.42

5.59

1.4

1.2

0.30

0.28

g/l

0.31

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

475

1.75

5.56

1.1

1.2

0.33

0.31

g/l

1.55

377

Mycoses

338

1.90

5.55

1.2

0.32

0.30

g/l

0.92

271

Other bacterial intestinal infections

177

2.27

5.53

1.2

0.31

0.30

g/l

0.34

144

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.14

5.52

1.3

0.35

0.27

g/l

2.15

Myocardial infarction, without ST-elevation

298

1.92

5.52

1.2

1.3

0.33

0.31

g/l

1.22

238

Other disorders of eyelid

459

1.75

5.52

1.3

1.2

0.31

g/l

0.02

377

Benign neoplasm: Small intestine

4.52

5.51

1.2

0.34

0.30

g/l

—

Symptoms and signs involving the urinary system

166

863

1.49

5.51

1.3

1.2

0.30

0.31

g/l

0.45

132

696

Crohn disease (strict definition, require KELA, min 2 HDR)

2.86

5.51

1.5

1.2

0.31

0.29

g/l

0.50

Conjunctivitis (acute, non atopic)

402

1.81

5.50

1.2

1.3

0.31

0.30

g/l

0.85

317

Other viral diseases

491

1.73

5.46

1.2

0.31

0.30

g/l

0.54

395

Exposure to other and unspecified inanimate mechanical forces

2.91

5.46

1.2

1.1

0.31

0.30

g/l

0.34

Other congenital malformations of skin

3.36

5.45

1.1

0.28

0.30

g/l

0.55

Budesonide

141

2.42

5.44

1.4

1.2

0.34

0.29

g/l

2.69

108

Gastric ulcer

135

2.45

5.43

1.3

1.2

0.34

0.31

g/l

1.00

102

Ulcerative colitis, NAS

185

2.22

5.43

1.3

1.2

0.31

0.30

g/l

0.48

152

Dental pulpitis 4, only avohilmo

280

1071

1.37

5.42

1.2

0.31

0.30

g/l

0.25

213

863

Substance abuse, excluding more controls

126

706

1.56

5.36

1.2

0.33

0.30

g/l

3.58

100

572

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

204

895

1.43

5.33

1.4

1.2

0.31

0.30

g/l

1.26

166

694

204

895

1.43

5.33

1.4

1.2

0.31

0.30

g/l

1.26

166

694

Childhood allergy (age < 16)

228

1.99

5.32

1.1

1.2

0.30

0.29

g/l

0.29

183

Candidiasis

168

2.27

5.28

1.2

0.33

0.29

g/l

1.46

136

Dental operations, only avohilmo

155

523

1.52

5.27

1.3

1.2

0.30

0.31

g/l

1.45

120

423

Anogenital herpesviral [herpes simplex] infection

102

2.66

5.24

1.3

1.2

0.28

g/l

0.14

Appendectomy

171

1134

1.45

5.24

1.2

0.31

g/l

0.01

132

898

Superficial injury of head

255

2.00

5.20

1.2

0.29

0.30

g/l

0.14

203

Diseases of liver

427

1.76

5.14

1.2

0.32

0.31

g/l

0.86

346

Other female pelvic inflammatory diseases

236

2.04

5.13

1.3

1.2

0.31

0.30

g/l

0.11

187

Fracture of foot, except ankle

341

1.85

5.10

1.3

1.2

0.33

0.30

g/l

2.33

276

Cholelithiasis, broad definition with cholecystitis

202

979

1.42

5.10

1.2

0.32

0.31

g/l

1.43

157

775

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

557

1.66

5.09

1.2

0.31

0.29

g/l

1.73

451

Car occupant injured in other and unspecified transport accidents

285

1.94

5.08

1.1

1.3

0.31

0.29

g/l

0.88

228

Speech disturbances, not elsewhere classified

2.85

5.08

1.0

1.2

0.32

0.30

g/l

0.61

Dental caries 2, only avohilmo

202

1134

1.41

5.03

1.2

0.30

g/l

0.59

165

885

Iron deficiency anaemia

500

1.69

5.01

1.2

0.32

0.31

g/l

0.59

406

Diabetes, insulin treatment (Kela reimbursement)

233

1033

1.38

5.01

1.2

0.33

0.30

g/l

3.71

188

823

Diseases of pulp and periapical tissues, including avohilmo

272

1045

1.35

4.99

1.2

0.31

0.30

g/l

0.22

208

846

Cluster headache, wide,, including avohilmo

2.98

4.99

1.1

1.2

0.29

g/l

0.01

Other and unspecified polyneuropathies, also in other diseases

179

2.18

4.98

1.0

1.2

0.31

g/l

0.32

140

Rheumatoid arthritis

338

1.80

4.94

1.1

1.2

0.33

0.31

g/l

1.89

268

Generalized anxiety disorder

233

2.02

4.93

1.1

1.2

0.31

0.29

g/l

1.11

188

Psoriasis

374

1.80

4.93

1.2

1.3

0.31

0.30

g/l

0.28

299

Dental pulpitis 1, only avohilmo

278

1080

1.35

4.92

1.2

0.31

0.30

g/l

0.19

210

870

Nasal polyp

193

2.13

4.92

1.2

0.31

g/l

0.04

154

Atrial fibrillation and flutter with reimbursement

153

2.06

4.92

1.3

1.2

0.33

0.31

g/l

1.18

128

Dental pulpitis 1

272

1048

1.35

4.92

1.2

0.31

0.30

g/l

0.32

208

848

COPD

354

1.75

4.91

1.2

1.3

0.34

0.31

g/l

2.06

281

Chronic periodontitis

142

2.33

4.90

1.3

0.32

0.30

g/l

0.59

111

Paroxysmal tachycardia

230

1.95

4.90

1.3

1.2

0.30

g/l

0.08

185

Heart failure and antihypertensive medication

132

2.16

4.89

1.2

0.34

0.30

g/l

2.30

104

Insulin, fast-acting

471

1.70

4.88

1.1

1.3

0.34

0.30

g/l

3.75

382

Diseases of middle ear and mastoid

153

854

1.47

4.87

1.2

0.30

g/l

0.06

128

673

Pain associated with micturition

149

2.29

4.85

1.3

0.30

g/l

0.05

117

Meniscus derangement

113

491

1.58

4.83

1.3

1.2

0.31

g/l

0.00

383

Acute nasopharyngitis (common cold)

124

2.41

4.80

1.1

1.2

0.32

0.29

g/l

0.82

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

224

993

1.38

4.79

1.2

0.33

0.30

g/l

3.95

181

790

Bell's palsy

125

2.41

4.79

1.5

1.2

0.29

0.30

g/l

0.51

100

Injuries to the head

268

1306

1.34

4.78

1.3

1.2

0.31

0.30

g/l

0.39

218

1027

Postprocedural endocrine and metabolic disorders, not elsewhere classified

176

2.17

4.77

1.2

0.32

0.30

g/l

0.70

147

Diseases of the digestive system

558

1.63

4.74

1.3

0.31

g/l

0.09

450

Other metabolic disorders

190

2.11

4.71

1.2

0.32

0.30

g/l

0.70

157

Gout, strict definition

126

2.39

4.71

1.1

1.3

0.33

0.31

g/l

0.79

Ventral hernia

265

1.93

4.70

1.2

0.31

g/l

0.12

212

Other disorders of adrenal gland

3.04

4.67

1.4

1.2

0.34

0.29

g/l

1.48

Dental pulpitis 4

270

1048

1.34

4.67

1.2

0.31

0.30

g/l

0.23

206

848

Artrosis, including avohilmo

205

806

1.40

4.65

1.2

0.31

g/l

0.17

169

630

Other chronic obstructive pulmonary disease

333

1.75

4.62

1.2

1.3

0.34

0.31

g/l

1.84

267

Disorders of lipoprotein metabolism and other lipidaemias

164

714

1.45

4.61

1.2

0.32

0.31

g/l

1.81

131

573

Special screening examination for other diseases and disorders

2.91

4.59

1.2

0.32

0.31

g/l

0.20

Bacterial intestinal infections, IBD co-morbidities

192

2.09

4.59

1.2

0.32

0.30

g/l

0.44

155

Leisure time condition

233

1.98

4.57

1.3

1.2

0.30

g/l

0.18

185

Personality disorders, excluding more controls

413

1.72

4.57

1.3

1.2

0.31

0.30

g/l

0.96

336

Cholelithiasis

191

959

1.40

4.56

1.3

1.2

0.32

0.31

g/l

1.62

149

761

Hyperlipidaemia, other/unspecified

369

1.75

4.56

1.1

1.3

0.32

0.31

g/l

0.27

293

Fracture at wrist and hand level

474

1.67

4.53

1.2

0.31

0.30

g/l

0.60

379

Gonarthrosis [arthrosis of knee](FG)

155

626

1.46

4.53

1.2

0.31

g/l

0.36

125

505

Polyuria

234

1.97

4.52

1.3

1.2

0.31

0.30

g/l

0.30

186

Type 2 diabetes

231

1011

1.36

4.50

1.3

1.2

0.32

0.30

g/l

3.27

186

803

Other Crohn's disease

2.66

4.48

1.6

1.2

0.32

0.29

g/l

1.06

Explicit Sepsis

470

1.65

4.48

1.3

1.2

0.34

0.30

g/l

2.63

375

Early onset COPD

242

1.95

4.47

1.1

1.3

0.35

0.31

g/l

2.14

192

Other follicular disorders

2.59

4.47

1.4

1.2

0.30

0.28

g/l

0.33

Unspecified kidney failure

2.93

4.44

1.1

1.2

0.35

0.29

g/l

1.52

Intestinal stricture

321

1.81

4.43

1.3

1.2

0.32

0.31

g/l

0.55

255

Crohn's disease NAS

2.70

4.41

1.7

1.2

0.30

0.29

g/l

0.12

Paralytic ileus and intestinal obstruction

250

1.92

4.41

1.3

1.2

0.32

0.31

g/l

0.52

199

Dental caries 1 and operation codes

193

708

1.40

4.40

1.3

1.2

0.30

0.31

g/l

0.88

147

568

Diabetes mellitus

249

1113

1.34

4.39

1.2

0.33

0.30

g/l

4.48

200

881

Sleep disorders

315

1.81

4.38

1.4

1.2

0.30

g/l

0.04

252

Ischaemic heart disease, wide definition

148

636

1.46

4.37

1.2

0.32

0.31

g/l

0.79

114

516

Other disorders involving the immune mechanism, not elsewhere classified

3.75

4.37

1.4

1.1

0.26

0.30

g/l

—

Benign neoplasm: Small intestine

3.74

4.37

1.2

1.1

0.34

0.31

g/l

—

Zoster [herpes zoster]

176

2.11

4.36

1.7

1.2

0.30

g/l

0.07

138

Menorrhagia

330

1.61

4.34

1.2

0.31

0.30

g/l

0.16

265

Reimbursement for rheumatic diseases

133

907

1.46

4.33

1.2

0.32

0.31

g/l

0.78

106

733

Dislocation, sprain and strain of joints and ligaments of knee

154

1004

1.43

4.32

1.3

1.2

0.31

0.30

g/l

0.28

125

807

Infections with a predominantly sexual mode of transmission

581

1.59

4.32

1.3

1.2

0.28

0.30

g/l

1.02

470

Septicaemia

404

1.69

4.29

1.3

1.2

0.34

0.30

g/l

2.67

326

Other diseases of anus and rectum

317

1.80

4.28

1.3

1.2

0.33

0.31

g/l

0.65

257

Diplopia

132

2.28

4.28

1.2

0.32

0.30

g/l

0.40

103

Neoplasms

216

850

1.36

4.26

1.2

0.30

g/l

0.02

177

678

Nonorganic sleeping disorders

282

1.85

4.25

1.3

1.2

0.30

g/l

0.08

228

Ganglion

282

1.85

4.25

1.2

0.31

0.29

g/l

1.25

219

Diabetes, varying definitions

246

1105

1.33

4.25

1.2

0.32

0.30

g/l

4.09

198

876

Psoriasis vulgaris

233

1.94

4.23

1.2

1.3

0.31

0.30

g/l

0.45

185

Amenorrhoea

108

2.42

4.22

1.2

1.1

0.30

0.29

g/l

0.23

Lichen planus

133

2.26

4.21

1.3

0.30

0.31

g/l

0.15

108

Umbilical hernia

334

1.77

4.20

1.2

0.30

g/l

0.03

272

Otitis externa

305

1.81

4.19

1.2

0.31

0.30

g/l

0.41

239

Other septicaemia

364

1.73

4.19

1.3

1.2

0.34

0.30

g/l

2.35

294

Hyperkinetic disorders, excluding more controls

142

2.20

4.18

1.3

1.1

0.30

0.28

g/l

0.47

113

Mental and behavioural disorders due to psychoactive substance use

131

849

1.46

4.15

1.2

0.33

0.30

g/l

3.27

103

685

Insulin, fast-acting or short human

494

1.62

4.14

1.1

1.2

0.34

0.30

g/l

3.64

400

Neuromuscular dysfunction of bladder

2.60

4.13

1.1

1.2

0.31

0.30

g/l

0.20

Diabetes medication

244

1119

1.33

4.13

1.2

0.32

0.30

g/l

3.87

194

891

IBD patients in KELA-register

344

1.75

4.10

1.3

1.2

0.31

0.30

g/l

0.68

282

Viral and other specified intestinal infections

307

1.79

4.10

1.4

1.2

0.30

0.29

g/l

0.73

246

Glomerular diseases

208

1.98

4.10

1.2

1.3

0.34

0.30

g/l

2.18

166

Angina pectoris

103

451

1.54

4.08

1.2

1.3

0.32

g/l

0.02

368

Substance abuse

126

824

1.46

4.08

1.2

0.33

0.30

g/l

3.82

100

662

Otitis externa, unspecified

148

2.17

4.07

1.2

0.31

0.29

g/l

0.90

118

Fall on and from stairs and steps

308

1.79

4.07

1.0

1.3

0.33

0.30

g/l

1.77

241

Paracetamol of NSAID medication

106

2.05

4.07

1.2

0.28

0.29

g/l

0.36

DVT of lower extremities and pulmonary embolism

457

1.64

4.05

1.3

1.2

0.33

0.31

g/l

1.95

366

Fenamates

110

2.15

4.03

1.3

1.2

0.31

0.30

g/l

0.25

Diseases of arteries, arterioles and capillaries (FINNGEN)

167

1.93

4.02

1.1

1.2

0.33

0.31

g/l

0.97

142

Cluster headache, strict, including avohilmo

2.77

4.02

1.1

1.2

0.28

0.29

g/l

0.13

Benign neoplasm of mouth and pharynx

117

2.32

4.00

1.4

1.2

0.31

0.30

g/l

0.34

Atrial fibrillation and flutter

231

1.75

4.00

1.3

1.2

0.33

0.30

g/l

1.99

190

Other diseases of pleura

413

1.63

3.99

1.3

0.34

0.31

g/l

2.87

332

Other and unspecified erythematous conditions

3.96

3.98

1.2

1.1

0.31

0.29

g/l

—

Nephropathy related operations

124

2.27

3.96

1.3

1.2

0.33

0.30

g/l

0.97

Psychotic depression

2.82

3.95

1.2

1.1

0.32

0.29

g/l

0.61

Misadventures to patients during surgical and medical care

150

2.14

3.95

1.3

1.2

0.30

g/l

0.05

120

Renal failure

386

1.66

3.94

1.1

1.3

0.36

0.31

g/l

4.80

311

Lesion of ulnar nerve

144

2.16

3.91

1.3

1.2

0.30

g/l

0.19

116

Superficial injury of abdomen, lower back and pelvis

191

2.00

3.91

1.2

0.32

0.30

g/l

0.92

147

Nontoxic multinodular goitre

205

1.96

3.90

1.2

1.3

0.31

g/l

0.06

166

Dental pulpitis 2

154

555

1.42

3.89

1.2

0.29

0.31

g/l

1.83

118

450

Acute appendicitis

171

1177

1.37

3.88

1.3

1.2

0.29

0.31

g/l

1.28

125

936

Cerebral palsy and other paralytic syndromes

138

2.18

3.88

1.2

0.32

0.29

g/l

1.41

113

Persons encountering health services for specific procedures, not carried out

2.46

3.88

1.3

1.1

0.29

0.28

g/l

0.13

Lichen planus, including avohilmo

206

1.95

3.85

1.3

1.2

0.31

g/l

0.03

166

Nonsuppurative otitis media

334

1.69

3.84

1.2

0.30

0.29

g/l

0.17

260

Impingement syndrome of shoulder

292

1.78

3.84

1.3

1.2

0.31

0.30

g/l

0.16

228

Pure hypercholesterolaemia

134

625

1.44

3.82

1.3

1.2

0.32

0.31

g/l

1.31

108

500

Insomnia

235

1.88

3.81

1.4

1.2

0.30

0.29

g/l

0.24

186

Polyp of the female genital tract

292

1.62

3.81

1.2

0.31

g/l

0.25

231

Other erythematous conditions

3.82

3.81

1.2

1.1

0.31

0.29

g/l

—

Other (not insulin) diabetes medications

215

973

1.33

3.80

1.3

1.2

0.33

0.30

g/l

3.43

173

776

Extrapyramidal and movement disorders

390

1.67

3.80

1.2

0.32

0.31

g/l

0.19

311

Benign neoplasm of mouth and pharynx

120

2.26

3.80

1.4

1.2

0.31

g/l

0.14

Sequelae of injuries of neck and trunk

3.56

3.77

1.0

1.2

0.32

0.29

g/l

0.89

Postprocedural disorders of nervous system

127

2.22

3.76

1.2

0.32

0.28

g/l

1.16

100

Chronic gastritis

272

1.80

3.76

1.2

0.31

0.32

g/l

0.27

216

Congenital malformations, deformations and chromosomal abnormalities

155

1073

1.39

3.76

1.3

1.2

0.30

g/l

0.24

116

853

Anomalies of dental arch relationship, including avohilmo

296

1.73

3.76

1.3

1.2

0.28

0.30

g/l

0.66

237

Mouth breathing

570

1.54

3.75

1.2

0.32

0.31

g/l

1.08

462

Inflammatory bowel disease, strict (require KELA)

355

1.69

3.71

1.3

1.2

0.31

0.30

g/l

0.64

289

Superficial injury of wrist and hand

281

1.78

3.70

1.3

1.2

0.30

0.29

g/l

0.09

228

Ischemic heart diseases

147

654

1.41

3.69

1.2

0.32

0.31

g/l

0.99

113

532

Disorders of adult personality and behaviour

510

1.57

3.68

1.2

0.31

0.30

g/l

0.85

411

Diseases of appendix

178

1203

1.35

3.65

1.2

0.30

0.31

g/l

0.73

131

954

Other disorders of the musculoskeletal system and connective tissue

162

2.04

3.64

1.1

1.2

0.31

0.30

g/l

0.09

127

Lichen ruber planus, wide definition including periferal and oral lichen planus

239

1.85

3.63

1.3

1.2

0.31

g/l

0.13

190

Other disorders of kidney and ureter

129

2.18

3.63

1.0

1.2

0.31

0.30

g/l

0.12

104

Reactive arthropathies

2.48

3.62

1.8

1.2

0.30

g/l

0.03

Oter anti-inflammatory and antirheumatic agents, non-steroids

112

1.98

3.62

1.2

0.31

g/l

0.03

Eating disorder

183

1.97

3.61

1.1

1.3

0.31

0.28

g/l

1.29

142

Disorders of breast

126

820

1.43

3.61

1.3

1.2

0.31

g/l

0.13

103

653

Deep bite

147

2.03

3.61

1.3

1.2

0.27

0.29

g/l

0.51

120

Appendicitis, broad definition

177

1203

1.35

3.59

1.2

0.30

0.31

g/l

0.90

130

954

Emotionally unstable personality disorder

226

1.86

3.58

1.0

1.2

0.34

0.29

g/l

2.96

180

Other disorders of skin and subcutaneous tissue, not elsewhere classified

150

2.07

3.56

1.2

0.33

0.30

g/l

1.94

115

Phlebitis and thrombophlebitis (not including DVT)

270

1.78

3.55

1.4

1.2

0.33

0.31

g/l

0.99

218

Specific personality disorders

406

1.63

3.54

1.2

0.32

0.29

g/l

1.69

322

Pregnancy examination and test

239

1.68

3.52

1.4

1.2

0.29

0.30

g/l

0.36

193

Other respiratory disorders and diseases

178

1.97

3.52

1.4

1.3

0.33

0.31

g/l

1.13

142

Other diseases of the respiratory system

178

1.97

3.52

1.4

1.3

0.33

0.31

g/l

1.13

142

Second line medication for Crohn's disease

131

933

1.41

3.50

1.2

0.32

0.30

g/l

1.85

109

747

Dental caries 3 and operation codes

199

765

1.34

3.50

1.2

0.30

0.31

g/l

0.56

153

614

Suppurative and unspecified otitis media

571

1.49

3.47

1.2

0.30

g/l

0.23

458

Other benign neoplasms of skin

446

1.59

3.46

1.2

0.31

g/l

0.06

363

Acute appendicitis, no complications

139

1000

1.39

3.46

1.2

0.29

0.31

g/l

1.39

102

806

Hard cardiovascular diseases

146

674

1.39

3.46

1.2

0.32

0.31

g/l

1.28

116

548

Other maternal disorders predominantly related to pregnancy

164

756

1.37

3.46

1.2

0.31

0.30

g/l

0.72

132

598

Dental pulpitis 2, only avohilmo

154

568

1.39

3.45

1.2

0.29

0.31

g/l

1.62

118

457

Spontaneous abortion

127

608

1.42

3.44

1.2

0.30

g/l

0.44

102

491

Dialysis, with operation codes

132

2.13

3.44

1.2

0.34

0.30

g/l

1.54

105

Diseases of arteries, arterioles and capillaries

112

576

1.45

3.44

1.2

0.32

0.31

g/l

1.28

464

Hypertrophy of breast in women and men

310

1.71

3.44

1.3

1.2

0.30

g/l

0.11

244

Maternal care for other conditions predominantly related to pregnancy

450

1.58

3.43

1.2

0.30

g/l

0.26

362

Ulcerative colitis

341

1.67

3.41

1.2

0.32

0.30

g/l

1.17

276

Superficial injury of shoulder and upper arm

126

2.15

3.41

1.3

1.2

0.31

0.29

g/l

0.63

104

Influenza and pneumonia

251

1291

1.28

3.39

1.3

1.2

0.31

0.30

g/l

1.23

199

1024

Transplanted organ and tissue status

107

2.25

3.38

1.1

1.2

0.34

0.30

g/l

1.60

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

225

1181

1.30

3.37

1.2

0.32

0.30

g/l

3.87

173

950

Achilles tendinitis

101

2.28

3.35

1.2

0.29

0.31

g/l

0.76

Injuries to the shoulder and upper arm

174

1094

1.33

3.32

1.2

0.31

g/l

0.11

137

875

Pleural effusion

121

2.15

3.31

1.2

1.3

0.34

0.30

g/l

1.41

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

375

1.63

3.30

1.5

1.3

0.32

0.30

g/l

1.37

304

Inflammatory disease of cervix uteri

2.48

3.29

1.4

1.2

0.27

0.30

g/l

1.02

Bleeding

158

848

1.36

3.29

1.2

0.32

0.31

g/l

0.62

121

686

Ulcer of lower limb, not elsewhere classified

115

2.18

3.27

1.1

1.3

0.36

0.29

g/l

2.98

Sacroiliitis, not elsewhere classified

2.79

3.25

1.7

1.2

0.29

0.28

g/l

—

Peripheral artery operations in Hilmo

2.34

3.23

1.1

1.3

0.36

0.30

g/l

1.87

Benign neoplasm: Sigmoid colon

170

1.95

3.22

1.2

0.31

0.32

g/l

0.08

135

Conduction disorders

242

1.72

3.22

1.2

0.31

g/l

0.06

197

Peripheral artery disease

320

1.61

3.22

1.2

1.3

0.34

0.31

g/l

2.55

253

Medical abortion

167

673

1.35

3.22

1.2

0.30

0.31

g/l

0.54

128

546

Hypertrophy of breast

287

1.71

3.19

1.2

0.30

g/l

0.07

224

Biguanides

203

959

1.31

3.19

1.3

1.2

0.32

0.30

g/l

2.67

164

767

Statin medication

170

712

1.34

3.15

1.2

0.32

0.30

g/l

3.36

138

555

Alcohol use disorder, ICD-based

564

1.49

3.12

1.2

0.34

0.30

g/l

3.85

451

Other extrapyramidal and movement disorders in other diseases

252

1.75

3.11

1.2

0.32

0.31

g/l

0.45

201

Other benign neoplasms of skin

468

1.54

3.11

1.2

0.31

g/l

0.01

374

5-aminosalicylic acid

252

1.75

3.11

1.2

0.30

0.29

g/l

0.48

198

Transient ischemic attack

472

1.49

3.10

1.2

1.3

0.31

g/l

0.01

379

Vestibular neuronitis

2.29

3.10

1.1

1.2

0.35

0.30

g/l

1.43

Glomerular disorders in diseases classified elsewhere

118

2.12

3.09

1.1

1.2

0.33

0.30

g/l

0.80

COPD, hospital admissions

381

1.56

3.09

1.2

1.3

0.34

0.31

g/l

1.69

307

Other and unspecified injuries of lower leg

2.33

3.07

1.4

1.2

0.31

0.29

g/l

0.60

Chronic pancreatitis

125

2.09

3.07

1.2

1.3

0.34

0.30

g/l

1.67

Female infertility

354

1.50

3.07

1.1

1.2

0.30

g/l

0.16

281

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.26

3.06

1.5

1.1

0.26

0.30

g/l

—

Nonalcoholic fatty liver disease

112

2.15

3.06

1.1

1.2

0.33

0.29

g/l

1.12

Crushed, pushed or stepped on by crowd or human stampede

2.23

3.06

1.3

1.2

0.32

0.29

g/l

0.69

Reactive arthropathies, FINNGEN

2.38

3.06

1.8

1.2

0.29

0.30

g/l

0.05

Mental and behavioural disorders due to alcohol

104

711

1.43

3.05

1.1

1.2

0.33

0.30

g/l

2.86

570

Other (seronegative) rheumatoid arthritis, wide

224

1.79

3.05

1.2

0.34

0.30

g/l

1.72

177

Type 2 diabetes, definitions combined

206

950

1.29

3.05

1.3

1.2

0.32

0.30

g/l

3.04

167

752

Benign neoplasm: Pituitary gland, craniopharyngeal duct

2.59

3.04

1.3

1.1

0.33

0.30

g/l

0.76

Type 2 diabetes, strict (exclude DM1)

206

951

1.29

3.04

1.3

1.2

0.32

0.30

g/l

3.04

167

753

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

455

1.54

3.03

1.2

0.31

0.29

g/l

0.76

372

Fracture of rib(s), sternum and thoracic spine

307

1.66

3.02

1.2

0.33

0.30

g/l

1.32

249

Mental and behavioural disorders due to alcohol, excluding acute intoxication

600

1.47

3.02

1.1

1.2

0.34

0.30

g/l

4.26

477

Infective dermatitis

106

2.18

3.02

1.4

1.2

0.31

0.30

g/l

0.25

Other bursopathies

133

2.03

3.00

1.5

1.3

0.29

0.30

g/l

0.28

Gastroduodenal ulcer

210

1.81

3.00

1.3

1.2

0.35

0.31

g/l

1.43

167

COPD, early/later onset

383

1.54

2.99

1.2

1.3

0.34

0.31

g/l

1.63

309

Herpesviral [herpes simplex] infections

147

1.98

2.99

1.7

1.2

0.34

0.30

g/l

1.24

116

Benign neoplasm: Sigmoid colon

175

1.89

2.99

1.2

0.31

g/l

0.11

139

Mental disorders, not otherwise specified

134

2.02

2.95

1.1

1.2

0.33

0.28

g/l

1.56

107

COPD-related respiratory insufficiency

2.28

2.93

1.1

1.2

0.34

0.30

g/l

1.56

Direct fill therapy

184

1.85

2.90

1.4

1.3

0.33

0.30

g/l

1.11

152

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

288

1.67

2.90

1.3

1.2

0.29

0.30

g/l

0.06

234

Cerebral aneurysm, nonruptured

2.22

2.89

1.2

0.32

0.30

g/l

0.38

Other diseases of the digestive system

319

1.63

2.88

1.3

1.2

0.31

g/l

0.01

252

Oxicams

134

1.78

2.88

1.3

1.2

0.31

g/l

0.05

106

117

779

1.38

2.86

1.1

1.2

0.33

0.30

g/l

2.25

621

Haemorrhoids and perianal venous thrombosis

289

1.66

2.85

1.2

0.31

g/l

0.09

232

Eating disorders

200

1.80

2.83

1.1

1.3

0.31

0.28

g/l

1.54

158

Spondylolisthesis/Spondylolysis

193

1.82

2.83

1.1

1.2

0.30

0.31

g/l

0.36

151

Type 2 diabetes, definitions combined, including avohilmo

206

953

1.28

2.83

1.3

1.2

0.32

0.30

g/l

2.68

165

757

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

3.08

2.81

1.1

0.30

g/l

0.05

GI-bleeding

314

1.63

2.79

1.1

1.2

0.31

g/l

0.16

245

Female infertility, cervigal, vaginal, other or unspecified origin

345

1.50

2.77

1.1

1.2

0.30

g/l

0.14

273

Complications predominantly related to the puerperium

506

1.49

2.77

1.4

1.2

0.30

g/l

0.13

410

Substance use, excluding alcohol

270

1.67

2.73

1.2

0.32

0.29

g/l

1.99

217

Aplastic and other anaemias

442

1.50

2.73

1.4

1.2

0.33

0.31

g/l

1.85

356

L04AX Other immunosuppressants

123

909

1.35

2.72

1.2

0.32

0.30

g/l

1.65

103

730

Covid-19 suspected case

348

1.58

2.71

1.2

0.30

0.29

g/l

0.09

279

Visual field defects

2.24

2.70

1.1

1.2

0.30

g/l

0.09

Exclusions for E4_PCOS_CONSORTIUM

190

929

1.28

2.69

1.2

0.32

0.30

g/l

1.84

157

728

Otitis media, unspecified

167

1.82

2.67

1.4

1.2

0.30

0.29

g/l

0.22

132

Spondylopathies (FG)

175

1.83

2.67

1.6

1.2

0.29

0.30

g/l

0.16

143

Abnormal weight loss

2.18

2.67

1.2

0.29

g/l

0.25

Superficial injury of thorax

168

1.85

2.66

1.1

1.3

0.33

0.30

g/l

1.50

136

Personality disorders

478

1.49

2.66

1.3

1.2

0.31

0.30

g/l

0.77

384

Benign neoplasm: Pituitary gland, craniopharyngeal duct

2.40

2.63

1.3

1.1

0.33

0.30

g/l

0.91

Dental caries 1, only avohilmo

167

654

1.31

2.63

1.3

1.2

0.30

0.31

g/l

0.69

129

522

Abnormal serum enzyme levels

300

1.61

2.62

1.2

1.3

0.33

0.30

g/l

1.47

240

Amputation

2.39

2.62

1.1

1.2

0.36

0.30

g/l

1.45

Dental caries, including avohilmo

162

632

1.31

2.62

1.3

1.2

0.30

0.31

g/l

0.82

124

506

Dental caries 1

162

632

1.31

2.61

1.3

1.2

0.30

0.31

g/l

0.82

124

506

Congenital malformations and deformations of the musculoskeletal system

140

1.92

2.61

1.1

1.2

0.30

0.29

g/l

0.37

117

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.16

2.60

1.4

1.1

0.30

0.29

g/l

0.05

Parodontitis, under 40 years and operation codes

148

1.90

2.60

1.1

1.2

0.31

0.28

g/l

1.19

113

Parodontitis, operation under 40 years and operation codes

148

1.90

2.60

1.1

1.2

0.31

0.28

g/l

1.19

113

Other/unspecified rheumatoid arthritis

127

1.97

2.59

1.3

1.2

0.32

0.30

g/l

0.41

102

Pedestrian injured in collision with pedal cycle

2.91

2.58

1.2

0.30

0.29

g/l

0.19

Volume depletion

2.30

2.57

1.1

1.2

0.33

0.30

g/l

0.65

Open wound of lower leg

156

1.86

2.56

1.2

1.3

0.33

0.30

g/l

1.28

126

Postmenopausal atrophic vaginitis

204

1.60

2.55

1.2

0.31

g/l

0.09

161

Disorders of continuity of bone

121

1.99

2.55

1.3

1.2

0.32

0.29

g/l

0.83

Other symptoms and signs involving the urinary system

101

2.08

2.52

1.2

0.38

0.30

g/l

2.28

Other spirochaetal diseases

316

1.58

2.50

1.6

1.2

0.30

0.31

g/l

0.09

250

Hypopituitarism

2.17

2.50

1.2

0.34

0.30

g/l

1.38

Type 1 diabetes

364

1.54

2.47

1.0

1.2

0.33

0.29

g/l

2.52

293

Fibroblastic disorders

232

1.68

2.47

1.1

1.2

0.34

0.30

g/l

1.86

177

Other and unspecified anaemias

407

1.50

2.46

1.4

1.2

0.34

0.31

g/l

1.90

326

Disorders of sclera, cornea, iris and ciliary body

113

841

1.35

2.44

1.2

0.31

0.30

g/l

0.37

668

Melanocytic naevi

439

1.48

2.43

1.2

0.30

g/l

0.17

350

Embedded teeth, including avohilmo

152

1.85

2.42

1.1

1.2

0.30

0.28

g/l

1.19

121

Other chronic obstructive pulmonary disease, including avohilmo

473

1.43

2.41

1.2

1.3

0.35

0.31

g/l

2.55

384

Other anaemias

408

1.49

2.41

1.4

1.2

0.34

0.31

g/l

1.87

327

Rheumatoid arthritis, including avohilmo

497

1.45

2.41

1.2

0.33

0.31

g/l

2.42

393

Carbimazole or st.post thyroidectomy, condition for graves disease

288

1.60

2.41

1.1

1.2

0.31

0.30

g/l

0.26

230

Other respiratory diseases principally affecting the interstitium

145

1.87

2.41

1.3

0.35

0.30

g/l

1.58

116

Melanocytic naevi

440

1.48

2.40

1.2

0.30

g/l

0.10

348

Pregnancy with abortive outcome

167

679

1.29

2.40

1.2

0.30

g/l

0.79

130

551

Chronic periodontitis, complicated

2.12

2.38

1.1

1.2

0.33

0.30

g/l

0.76

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

342

1.52

2.36

1.3

1.2

0.29

g/l

0.05

278

Benign neoplasm of other and unspecified endocrine glands

146

1.85

2.36

1.2

1.3

0.33

0.30

g/l

1.38

115

Thyroiditis, ILD-related definition

168

1.79

2.36

1.3

1.2

0.30

0.29

g/l

0.36

135

Other or unspecified ileus, impaction or obstruction

168

1.79

2.35

1.4

1.2

0.32

0.31

g/l

0.81

133

Other disorders starting during childhood or adolecense, excluding more controls

2.34

2.35

1.3

1.1

0.27

0.29

g/l

—

Other/unspecified reactive arthropathies

2.15

2.34

1.8

1.2

0.30

0.29

g/l

0.13

Retinal vascular occlusion

2.15

2.34

1.0

1.2

0.34

0.30

g/l

1.06

Retinal vascular disorders

2.15

2.34

1.0

1.2

0.34

0.30

g/l

1.06

Nummular dermatitis

2.26

2.34

1.1

1.2

0.34

0.30

g/l

—

Spondyloarthritis

236

1.66

2.34

1.5

1.2

0.31

0.30

g/l

0.54

188

Lyme disease

314

1.56

2.34

1.7

1.2

0.30

0.31

g/l

0.16

248

Salpingitis and oophoritis

252

1.63

2.32

1.3

1.2

0.32

0.31

g/l

0.32

203

Benign neoplasm of other and unspecified endocrine glands

147

1.84

2.32

1.2

1.3

0.33

0.30

g/l

1.03

117

Atherosclerosis, excluding cerebral and coronary sclerosis

282

1.53

2.29

1.2

1.3

0.34

0.31

g/l

1.85

222

Disorders of refraction and accommodation

435

1.47

2.29

1.3

1.2

0.31

0.30

g/l

0.55

352

Propionic acid derivatives

190

1.54

2.28

1.2

0.28

0.30

g/l

1.55

154

Anti-inflammatory and antirheumatic products, non-steroids

190

1.54

2.28

1.2

0.28

0.30

g/l

1.04

154

Dental caries 3, only avohilmo

176

710

1.27

2.27

1.3

1.2

0.30

0.31

g/l

0.27

137

568

120

816

1.32

2.26

1.1

1.2

0.33

0.30

g/l

2.48

653

Parodontitis, under 40 years

156

1.80

2.25

1.1

1.2

0.31

0.28

g/l

1.00

120

Additional codes for the location of defect, injury or illness

2.28

2.24

1.1

1.2

0.31

0.28

g/l

—

Dental caries 3

172

693

1.27

2.23

1.3

1.2

0.30

0.31

g/l

0.45

132

555

Gonarthrosis,primary

165

818

1.27

2.22

1.1

1.2

0.32

0.31

g/l

0.32

135

653

Injuries to the hip and thigh

500

1.41

2.22

1.2

1.3

0.32

0.31

g/l

0.57

400

Follicular cysts of skin and subcutaneous tissue

209

1.68

2.22

1.1

1.2

0.33

0.30

g/l

1.18

169

Senile cataract

105

482

1.35

2.22

1.2

0.33

0.31

g/l

1.62

395

Parodontitis, under 40 years, or operation codes

157

1.79

2.21

1.1

1.2

0.31

0.28

g/l

1.00

121

Disorders of vitreous body and globe

584

1.39

2.20

1.2

0.31

g/l

0.10

473

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

107

1.97

2.20

1.2

0.31

0.29

g/l

0.44

Coeliac disease

165

1.76

2.18

1.3

0.30

g/l

0.06

133

Fissure and fistula of anal and rectal regions

288

1.56

2.18

1.2

0.32

0.30

g/l

1.02

231

Haemorrhage in early pregnancy

537

1.40

2.17

1.2

0.29

0.30

g/l

0.39

424

Other menopausal disorders

246

1.48

2.16

1.3

1.2

0.30

0.31

g/l

0.47

193

Premenstrual syndrome

3.73

2.16

1.0

1.1

0.33

0.29

g/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

123

826

1.30

2.15

1.2

0.30

g/l

0.06

654

Pregnancy hypertension

114

781

1.32

2.15

1.3

1.2

0.30

g/l

0.23

619

Biological medication for rheuma

242

1.62

2.15

1.4

1.2

0.32

0.30

g/l

0.85

193

Weight loss

101

1.99

2.15

1.2

0.29

0.30

g/l

0.28

Otalgia

108

1.95

2.15

1.2

0.31

0.29

g/l

0.44

Pulmonary heart disease, diseases of pulmonary circulation

329

1.52

2.14

1.3

1.2

0.33

0.31

g/l

0.75

257

Disorders of vitreous body

573

1.38

2.14

1.2

0.31

g/l

0.01

463

Benign neoplasm of other and ill-defined parts of digestive system

197

1.68

2.11

1.2

0.34

0.30

g/l

1.38

153

Aneurysms, operations, SAH

167

1.74

2.10

1.4

1.3

0.32

0.31

g/l

0.23

129

Coronary atherosclerosis

108

524

1.33

2.09

1.2

0.32

0.31

g/l

0.64

426

334

1.49

2.08

1.1

1.3

0.32

g/l

0.21

273

Benign neoplasm of other and ill-defined parts of digestive system

198

1.67

2.08

1.2

0.34

0.31

g/l

0.87

159

Acute alcohol intoxication

324

1.51

2.07

1.2

1.3

0.32

0.30

g/l

1.11

261

Alcohol use disorder, Swedish definition

103

721

1.33

2.07

1.1

1.2

0.34

0.30

g/l

3.15

572

Acute pancreatitis

206

1.65

2.06

1.2

0.33

0.30

g/l

1.71

167

Endometriosis of ovary

252

1.59

2.06

1.2

0.31

0.30

g/l

0.19

198

Skin changes due to chronic exposure to nonionizing radiation

299

1.52

2.05

1.1

1.3

0.32

g/l

0.06

242

Disorders of choroid and retina

140

799

1.28

2.05

1.2

0.31

g/l

0.25

115

639

Actinic keratosis

285

1.53

2.05

1.1

1.3

0.32

g/l

0.04

229

Dislocation, sprain and strain of joints and ligaments of head

2.33

2.05

1.5

1.2

0.33

0.29

g/l

—

Acute suppurative otitis media

457

1.41

2.03

1.1

1.2

0.30

0.29

g/l

0.22

364

Acute alcohol intoxication, ICD10

254

1.58

2.02

1.2

1.3

0.31

0.30

g/l

0.35

202

Other inflammatory liver diseases

2.11

2.02

1.3

1.2

0.34

0.30

g/l

—

Disturbance of activity and attention

182

1.69

2.02

1.3

1.2

0.30

0.28

g/l

0.54

143

Benign neoplasm: Rectum

162

1.73

2.01

1.0

1.2

0.34

0.32

g/l

0.72

132

Myocarditis

2.51

2.01

1.5

1.2

0.32

0.29

g/l

—

Other disorders of the genitourinary system

140

1.79

2.00

1.2

0.32

0.31

g/l

0.17

112

Striking against or struck by other objects

500

1.40

2.00

1.4

1.2

0.29

0.30

g/l

0.27

401

Ptosis of eyelid

1.96

2.00

1.4

1.2

0.32

0.31

g/l

0.10

Other mental disorders due to brain damage and dysfunction and to physical disease

1.96

2.00

1.2

0.30

g/l

0.07

Poisoning by medicine

352

1.48

1.98

1.1

1.2

0.31

0.29

g/l

1.12

283

Hordeolum and other deep inflammation of eyelid

2.15

1.98

1.1

0.31

0.30

g/l

0.37

Embedded and impacted teeth

454

1.39

1.96

1.2

0.30

0.29

g/l

0.68

369

Other pleural conditions

2.08

1.96

1.2

0.35

0.29

g/l

1.42

Bacterial pneumonia, not elsewhere classified

421

1.41

1.96

1.4

1.2

0.33

0.31

g/l

1.45

340

Acute renal failure

171

1.70

1.96

1.2

1.3

0.37

0.30

g/l

3.10

138

Kidney transplant status

2.36

1.95

1.0

1.2

0.35

0.29

g/l

—

Ankylosing spondylitis

1.98

1.95

1.4

1.2

0.31

g/l

0.25

Tooth eruption problems

270

1.54

1.94

1.1

1.2

0.31

0.28

g/l

1.34

217

Medical treatment for female infertility

477

1.40

1.94

1.1

1.2

0.29

0.30

g/l

0.30

382

Myocardial infarction

383

1.39

1.93

1.2

1.3

0.33

0.32

g/l

0.50

313

Type 1 diabetes, wide definition, subgroup 1

314

1.50

1.91

1.0

1.2

0.32

0.29

g/l

1.55

254

Impacted teeth

330

1.47

1.91

1.3

1.2

0.29

g/l

0.24

264

Retention of urine

299

1.47

1.90

1.2

1.3

0.31

0.30

g/l

0.11

237

Ménière disease

1.92

1.90

1.2

0.33

0.30

g/l

0.63

Disorders of ocular muscles, binocular movement, accommodation and refraction

108

826

1.30

1.90

1.3

1.2

0.32

0.30

g/l

0.96

676

Fall on same level involving ice and snow

113

877

1.29

1.89

1.2

0.31

g/l

0.14

708

Peritonsillar abscess

291

1.51

1.88

1.3

1.2

0.31

0.30

g/l

0.34

231

COPD (mode)

204

1.56

1.88

1.2

0.32

0.31

g/l

0.29

158

COPD, hospital admissions 3, with asthma pneumonia sepsis

179

1.62

1.88

1.3

1.2

0.34

0.31

g/l

0.90

139

Bitten or struck by other mammals

166

1.69

1.87

1.3

1.2

0.30

0.29

g/l

1.16

134

COPD related to multimorbidity

299

1.47

1.87

1.2

1.3

0.33

0.31

g/l

0.72

238

Pulmonary heart disease

308

1.49

1.86

1.3

1.2

0.33

0.31

g/l

0.72

242

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

211

1231

1.20

1.86

1.3

1.2

0.31

0.30

g/l

1.10

170

985

Suicide or other Intentional self-harm

391

1.43

1.84

1.2

0.32

0.30

g/l

1.13

314

Pulmonary embolism

309

1.49

1.84

1.3

1.2

0.33

0.31

g/l

0.73

243

Sub-endpoint used in defining T1D endpoints

393

1.43

1.83

1.0

1.3

0.33

0.30

g/l

2.19

315

Benign neoplasm: Rectum, anus and anal canal

190

1.63

1.83

1.2

0.33

0.32

g/l

0.19

154

Other and unspecified disorders of vitreous body

456

1.40

1.83

1.2

0.30

0.31

g/l

0.90

367

Other diseases of blood and blood-forming organs, wide

269

1.53

1.83

1.3

1.2

0.33

0.30

g/l

1.21

216

Other hammer toe(s) (acquired)

142

1.72

1.83

1.2

0.31

0.32

g/l

0.26

115

Cerebrovascular diseases

119

666

1.28

1.83

1.2

0.32

0.31

g/l

1.20

538

All pneumoniae

220

1268

1.20

1.82

1.3

1.2

0.32

0.30

g/l

1.69

178

1009

ILD, hospital admissions 1, main diag only

115

1.83

1.82

1.3

0.35

0.30

g/l

1.07

Retinal detachments and breaks

351

1.45

1.81

1.1

1.3

0.31

g/l

0.00

278

Seropositive rheumatoid arthritis

277

1.51

1.81

1.1

1.2

0.33

0.31

g/l

1.39

224

Left bundle-branch block

2.27

1.80

1.3

1.2

0.29

0.30

g/l

—

Disorders of parathyroid gland

204

1.60

1.80

1.2

1.3

0.33

0.31

g/l

0.61

166

Enterocolitis due to Clostridium difficile

1.92

1.79

1.1

1.2

0.35

0.31

g/l

1.97

Myocardial infarction, strict

358

1.39

1.79

1.2

1.3

0.33

0.32

g/l

0.83

292

Endometriosis diagnosis and infertility diagnosis occurring together

207

1.60

1.79

1.1

1.2

0.29

g/l

0.10

165

Poisoning by drugs, medicaments and biological substances

394

1.42

1.78

1.1

1.2

0.32

0.29

g/l

1.38

321

Tinnitus

279

1.51

1.78

1.3

1.2

0.29

0.31

g/l

1.23

223

Epilepsy

368

1.44

1.78

1.3

1.2

0.30

0.31

g/l

0.04

295

Injury of other and unspecified intrathoracic organs

2.17

1.77

1.0

1.2

0.32

0.29

g/l

—

Unstable angina pectoris

291

1.45

1.77

1.2

1.3

0.34

0.31

g/l

1.29

236

Arthropod-borne viral fevers and viral haemorrhagic fevers

109

1.84

1.77

1.4

1.2

0.30

0.29

g/l

0.09

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

154

1.69

1.76

1.3

1.1

0.32

0.29

g/l

0.70

127

Coagulation defects, purpura and other haemorrhagic conditions

248

1.53

1.75

1.1

1.3

0.33

0.30

g/l

1.32

193

Hallux valgus (acquired)

296

1.42

1.74

1.1

1.2

0.30

0.31

g/l

0.90

233

Hyperkinetic disorders

198

1.60

1.74

1.3

1.2

0.30

0.28

g/l

0.56

158

Extracorporeal dialysis

2.23

1.74

1.1

1.2

0.34

0.30

g/l

—

Benign neoplasm: Rectum

170

1.65

1.73

1.0

1.3

0.34

0.31

g/l

1.25

132

Hyperparathyroidism

168

1.65

1.72

1.2

0.33

0.31

g/l

0.42

135

Excessive attrition of teeth

373

1.33

1.72

1.2

1.3

0.31

0.29

g/l

0.94

296

Routine general health check-up of defined subpopulation

2.93

1.72

1.0

0.29

g/l

—

Open wound of wrist and hand

638

1.32

1.72

1.3

1.2

0.30

g/l

0.21

506

Other abnormal products of conception

478

1.31

1.72

1.2

0.29

0.30

g/l

1.17

388

Pneumonias (Asthma/COPD co-morbidities)

217

1263

1.19

1.71

1.3

1.2

0.32

0.30

g/l

1.41

175

1005

Benign neoplasm: Rectum, anus and anal canal

194

1.60

1.71

1.2

1.3

0.33

0.31

g/l

0.49

155

Ulcer of oesophagus

2.30

1.70

1.5

1.2

0.30

g/l

—

Type 1 diabetes, wide definition

331

1.45

1.70

1.0

1.2

0.32

0.29

g/l

1.48

267

Acute pancreatitis (for exclusion)

218

1.56

1.70

1.2

0.33

0.30

g/l

1.70

174

Other disorders of veins

551

1.34

1.69

1.2

0.31

g/l

0.07

442

Fracture of lumbar spine and pelvis

210

1.57

1.69

1.2

0.32

0.31

g/l

0.30

164

Acute tubulo-interstitial nephritis

121

853

1.26

1.69

1.3

1.2

0.32

0.30

g/l

2.47

694

Abrasion of teeth

316

1.40

1.67

1.3

0.29

0.30

g/l

0.37

251

Lichen simplex chronicus and prurigo

2.19

1.67

1.2

0.37

0.29

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

456

1.37

1.66

1.2

0.30

g/l

0.54

357

Superficial injury of hip and thigh

149

1.68

1.66

1.1

1.2

0.32

0.30

g/l

0.47

117

Presence of other functional implants

463

1.32

1.64

1.2

0.32

0.31

g/l

1.12

369

AV-block

108

1.77

1.63

1.3

1.2

0.30

g/l

0.12

Parodontitis

177

1082

1.21

1.63

1.2

0.33

0.30

g/l

3.17

138

863

Chronic periodontitis, including avohilmo

176

1080

1.21

1.62

1.2

0.33

0.30

g/l

3.19

138

860

Dental caries 2 and operation codes, only avohilmo

173

887

1.21

1.62

1.2

0.30

g/l

0.70

144

687

Parodontitis or operation codes

177

1083

1.20

1.61

1.2

0.33

0.30

g/l

3.18

138

864

Bacterial pneumonia (organism specified)

490

1.34

1.61

1.4

1.2

0.33

0.31

g/l

1.32

388

Pneumonia, organism unspecified

186

1123

1.20

1.60

1.3

1.2

0.31

0.30

g/l

0.89

153

901

Fracture of shoulder and upper arm

428

1.38

1.60

1.4

1.3

0.31

0.30

g/l

0.15

343

Other interstitial pulmonary diseases

128

1.72

1.60

1.3

0.35

0.30

g/l

1.17

101

Combinations of oral blood glucose lowering drugs

295

1.46

1.59

1.2

0.34

0.31

g/l

0.80

238

Injury of muscle and tendon at shoulder and upper arm level

412

1.38

1.59

1.3

1.2

0.31

g/l

0.05

332

Bacterial pneumoniae

455

1.34

1.58

1.3

1.2

0.33

0.30

g/l

1.63

371

Primary gonarthrosis, bilateral

488

1.33

1.56

1.2

1.3

0.31

g/l

0.02

398

Preterm labour and delivery

456

1.36

1.56

1.4

1.2

0.29

0.31

g/l

1.04

367

ILD, hospital admissions

129

1.71

1.56

1.3

0.35

0.30

g/l

1.17

101

Interstitial lung disease

129

1.71

1.56

1.3

0.35

0.30

g/l

1.17

101

Interstitial lung disease endpoints

129

1.71

1.56

1.3

0.35

0.30

g/l

1.17

101

Glomerulonephritis

114

1.76

1.56

1.2

0.37

0.30

g/l

3.71

Care involving dialysis

1.89

1.54

1.1

1.2

0.36

0.29

g/l

—

Atrophic disorders of skin

176

1.59

1.54

1.2

0.33

0.30

g/l

1.24

142

Tobacco use

2.04

1.54

1.5

1.1

0.31

0.29

g/l

0.53

Bipolar affective disorders

281

1.46

1.53

1.2

0.34

0.29

g/l

2.20

231

Unspecified lump in breast

216

1.53

1.2

0.33

0.31

g/l

1.13

170

Dental pulpitis 3, only avohilmo

180

1.50

1.52

1.3

1.2

0.28

g/l

0.09

147

Parodontitis and operation codes

165

1067

1.20

1.51

1.2

0.33

0.30

g/l

2.96

129

853

Seborrhoeic keratosis

217

1.52

1.50

1.2

1.3

0.34

0.31

g/l

1.31

174

Dysplasia of cervi uteri

335

1.36

1.47

1.2

0.28

0.30

g/l

1.47

262

Campylobacter enteritis

2.51

1.45

1.3

1.1

0.29

0.28

g/l

—

Injuries involving multiple body regions

2.12

1.44

1.4

1.1

0.33

0.28

g/l

—

Contraceptive management

532

1.27

1.44

1.3

1.2

0.29

0.31

g/l

0.97

424

L02BG Aromatase inhibitors

344

1.40

1.43

1.2

0.34

0.31

g/l

1.08

281

Disorders of lens

116

589

1.24

1.43

1.1

1.2

0.33

0.31

g/l

2.22

481

Uterine polyps

125

1.68

1.43

1.1

0.32

0.31

g/l

0.12

103

Fentanyl

1.97

1.43

1.1

1.3

0.32

0.30

g/l

—

Other hearing loss

257

1.45

1.41

1.4

1.2

0.31

0.32

g/l

0.04

207

Colonic or urogenital fistula

346

1.39

1.2

0.33

0.30

g/l

1.38

275

Unspecified acute lower respiratory infection

173

1.56

1.39

1.0

1.2

0.32

0.30

g/l

0.73

141

Diseases of male genital organs

315

1.30

1.39

1.2

1.3

0.30

0.31

g/l

1.17

250

Testicular dysfunction

2.42

1.39

1.9

1.2

0.33

0.29

g/l

—

Keratitis

492

1.32

1.39

1.3

1.2

0.31

0.30

g/l

0.12

390

Other diseases of blood and blood-forming organs

1.90

1.39

1.3

1.2

0.35

0.30

g/l

—

Major coronary heart disease event excluding revascularizations

507

1.27

1.38

1.2

1.3

0.33

0.31

g/l

1.05

411

Other sleep disorders

119

1.68

1.37

1.4

1.2

0.32

0.30

g/l

0.51

Muscle strain

2.20

1.37

1.1

1.2

0.32

0.28

g/l

—

Other and unspecified mononeuropathies of lower limb

2.62

1.37

1.5

1.1

0.28

g/l

—

Alcohol abuse, main dg, excluding more controls

182

1.54

1.36

1.2

1.3

0.30

0.29

g/l

0.25

146

Artificial joint operation, meniscal resection

163

911

1.19

1.35

1.2

0.32

0.31

g/l

0.89

129

729

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

273

1.43

1.34

1.2

0.30

0.29

g/l

0.19

224

Other fall from one level to another

315

1.40

1.34

1.4

1.3

0.31

0.29

g/l

0.80

250

Injury of muscle and tendon at lower leg level

175

1.55

1.34

1.2

1.3

0.31

0.29

g/l

0.60

142

Exposure to other and unspecified animate mechanical forces

2.15

1.34

1.1

0.31

0.30

g/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

540

1.30

1.32

1.2

0.31

0.30

g/l

0.64

435

Pedal cyclist injured in transport accident

308

1.40

1.31

1.4

1.2

0.32

0.30

g/l

1.34

244

Trigger finger

152

1.58

1.31

1.3

1.2

0.33

0.30

g/l

1.22

117

Dental pulpitis 3

190

1.44

1.31

1.3

1.2

0.28

0.29

g/l

0.06

155

Other retinal disorders

618

1.25

1.30

1.2

0.32

0.31

g/l

0.27

492

Pre-eclampsia or eclampsia

411

1.34

1.30

1.2

0.30

g/l

0.00

332

Persons encountering health services in circumstances related to reproduction

122

680

1.22

1.28

1.2

0.30

0.31

g/l

0.94

547

Mucosal proctocolitis

169

1.54

1.28

1.3

1.2

0.31

0.29

g/l

0.43

136

Thyrotoxicosis

344

1.37

1.27

1.1

1.2

0.32

0.30

g/l

0.70

270

Coxarthrosis

378

1.29

1.27

1.2

0.31

g/l

0.04

303

Supervision of high-risk pregnancy

289

1.32

1.26

1.3

1.2

0.29

0.30

g/l

0.70

232

Pregnancy, childbirth and the puerperium

263

1.31

1.25

1.2

0.29

0.31

g/l

1.39

215

Renal tubulo-interstitial diseases

172

1124

1.17

1.25

1.2

0.33

0.30

g/l

3.43

133

909

Stroke, excluding SAH

495

1.26

1.25

1.2

1.3

0.32

0.31

g/l

0.29

395

Benign neoplasm: Liver

2.41

1.24

1.0

1.1

0.32

0.29

g/l

—

Fall involving bed

2.41

1.24

1.2

1.1

0.35

0.32

g/l

—

Disorders of calcium metabolism

1.91

1.22

1.0

1.3

0.35

0.29

g/l

1.97

Assault by bodily force

108

1.67

1.22

1.6

1.2

0.32

0.29

g/l

0.51

Chronic ulcer of skin, not elsewhere classified

1.97

1.22

1.1

1.2

0.38

0.29

g/l

—

Personal history of other diseases and conditions

195

1.48

1.21

1.3

1.2

0.34

0.28

g/l

1.59

160

Chronic tubulo-interstitial nephritis

2.17

1.21

1.4

1.1

0.36

0.28

g/l

—

Tumor necrosis factor alpha inhibitors

221

1.45

1.20

1.4

1.2

0.31

0.30

g/l

0.66

179

Other disorders starting during childhood or adolescence

1.76

1.20

1.3

1.2

0.27

0.29

g/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.11

1.18

2.3

1.0

0.31

0.29

g/l

—

Stroke, including SAH

550

1.24

1.18

1.2

1.3

0.32

0.31

g/l

0.49

440

Adhesive capsulitis of shoulder

173

1.50

1.17

1.4

1.2

0.33

0.30

g/l

0.67

131

Other maltreatment syndromes

0.00

1.16

0.0

1.2

—

0.28

—

Gestational [pregnancy-induced] hypertension

542

1.27

1.15

1.3

1.2

0.29

0.30

g/l

0.14

436

Other and unspecified hydrocephalus

2.51

1.15

1.0

1.2

0.32

g/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.06

1.15

1.4

1.1

0.30

g/l

—

Use of pramipexole

232

1.42

1.14

1.4

1.2

0.31

g/l

0.00

182

Toxic effects of substances chiefly nonmedicinal as to source

142

1.55

1.14

1.4

1.2

0.28

0.29

g/l

0.22

115

Diagnoses used for exclusion with ILD

283

1.38

1.13

1.3

1.2

0.34

0.31

g/l

2.37

233

Fibrosis and cirrhosis of liver

1.85

1.13

1.3

1.2

0.31

0.29

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1.71

1.11

1.3

1.2

0.29

g/l

—

ILD, hospital admission 2, with pulmonary infections

1.78

1.10

1.1

1.3

0.37

0.30

g/l

—

Ischaemic Stroke, excluding all haemorrhages

452

1.25

1.10

1.2

1.3

0.32

0.31

g/l

0.58

360

Single delivery by forceps and vacuum extractor

238

0.69

1.10

1.1

1.2

0.28

0.30

g/l

1.26

187

Later onset COPD, excluding more controls

111

1.55

1.09

1.2

1.3

0.33

0.32

g/l

0.26

Juvenile arthritis (FINNGEN)

1.82

1.09

1.0

1.2

0.31

0.28

g/l

0.73

Restless leg syndrome

144

1.53

1.08

1.1

1.2

0.32

0.30

g/l

0.80

114

Thyrotoxicosis, other and/or unspecified

261

1.38

1.07

1.1

1.2

0.32

0.30

g/l

0.76

207

Postmenopausal bleeding

193

1.34

1.06

1.3

1.2

0.33

0.31

g/l

0.55

155

Other disorders of ear

176

1017

1.15

1.05

1.2

0.30

0.31

g/l

0.57

138

820

Haemangioma and lymphangioma, any site

113

1.60

1.05

1.3

1.2

0.30

g/l

0.03

Benign neoplasm: Skin of other and unspecified parts of face

121

1.57

1.05

1.2

0.31

0.30

g/l

0.45

COPD, hospital admissions 1, only main diagnosis

259

1.35

1.04

1.1

1.3

0.34

0.31

g/l

0.83

203

Other misadventures during surgical and medical care

2.28

1.03

1.2

1.1

0.31

0.26

g/l

—

Other medical care

461

1.27

1.03

1.2

0.30

0.31

g/l

0.15

370

Haemangioma and lymphangioma, any site

114

1.58

1.02

1.3

1.1

0.30

0.29

g/l

0.10

Benign neoplasm: Skin of other and unspecified parts of face

122

1.56

1.02

1.2

0.31

0.30

g/l

0.25

Alcohol abuse, main dg

196

1.43

1.01

1.2

1.3

0.30

0.29

g/l

0.22

158

Other and unspecified glaucoma

1.89

1.01

1.1

1.2

0.35

0.30

g/l

—

Sarcoidosis

155

1.49

1.00

1.4

1.2

0.34

0.30

g/l

1.70

124

Other obstetric conditions, not elsewhere classified

101

547

1.20

0.98

1.2

0.30

0.29

g/l

0.37

438

Fracture of lower leg, including ankle

816

1.20

0.98

1.2

0.32

0.30

g/l

1.67

655

Gonarthrosis, primary, with knee surgery

490

1.23

0.98

1.2

1.3

0.32

0.31

g/l

0.34

397

Glaucoma suspect

388

1.29

0.97

1.2

0.32

0.31

g/l

0.50

308

Other specified disorders of kidney and ureter

1.95

0.97

1.0

1.1

0.32

0.29

g/l

—

Disorders of eyelid in diseases classified elsewhere

1.95

0.97

1.1

0.32

0.30

g/l

—

Pericarditis

1.95

0.97

1.3

1.2

0.33

0.28

g/l

—

Acne vulgaris

132

1.52

0.97

1.2

0.28

g/l

0.10

109

Ankylosing spondylitis, ICD10

116

1.55

0.96

1.4

1.2

0.31

0.29

g/l

0.85

Postpartum care and examination

218

1.32

0.96

1.2

0.31

0.30

g/l

0.62

174

Endometriosis ASRM stages 3,4

398

1.28

0.95

1.1

1.2

0.30

g/l

0.07

317

Thyrotoxicosis with diffuse goitre

199

1.41

0.95

1.1

1.2

0.31

0.30

g/l

0.45

159

Acne

174

1.44

0.94

1.5

1.2

0.28

g/l

0.00

143

Atopic conjunctivitis

1.77

0.94

1.1

0.27

0.29

g/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

234

1.37

0.94

1.1

1.2

0.30

0.29

g/l

0.25

190

Right bundle-branch block

2.23

0.93

1.2

1.1

0.32

0.29

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

158

1.46

0.93

1.3

1.2

0.29

0.31

g/l

0.53

124

Pacemaker

261

1.34

0.92

1.4

1.3

0.32

0.31

g/l

0.23

208

Degeneration of macula and posterior pole

329

1.28

0.92

1.3

0.31

0.32

g/l

0.26

261

Eustachian salpingitis and obstruction

134

1.50

0.91

1.2

0.31

0.29

g/l

0.65

106

Perineal laceration during delivery

332

0.72

0.90

1.2

0.29

g/l

0.09

261

Haemangioma, any site

102

1.57

0.90

1.1

0.32

0.29

g/l

0.44

Pre-eclampsia

384

1.28

0.90

1.2

0.30

g/l

0.14

309

Adjustment and management of implanted device

143

1.47

0.89

1.2

0.35

0.31

g/l

2.32

117

Normal-pressure hydrocephalus

2.07

0.89

1.0

1.2

0.28

0.31

g/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.59

0.89

1.3

1.2

0.27

0.28

g/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

536

1.19

0.88

1.2

0.30

0.29

g/l

0.24

429

Haemangioma, any site

103

1.56

0.87

1.1

1.2

0.32

0.30

g/l

0.32

Procedures for purposes other than remedying health state

2.01

0.87

1.7

1.1

0.30

0.29

g/l

—

Family history of malignant neoplasm

161

1.43

0.86

1.0

1.2

0.32

0.29

g/l

1.48

131

Unspecified haematuria

407

1.24

0.86

1.3

1.2

0.30

0.31

g/l

0.31

330

Benign neoplasm: Skin of eyelid, including canthus

161

1.43

0.86

1.3

0.29

0.31

g/l

0.31

129

Assault

195

1.39

0.86

1.4

1.2

0.31

0.29

g/l

0.52

154

Heterophoria

120

1.50

0.85

1.2

0.30

0.28

g/l

—

Other benign neoplasms of connective and other soft tissue

120

1.50

0.85

1.3

1.2

0.36

0.29

g/l

1.50

Coxarthrosis [arthrosis of hip](FG)

435

1.21

0.85

1.2

0.31

g/l

0.20

361

Redundant prepuce, phimosis and paraphimosis

203

1.37

0.85

1.0

1.3

0.29

0.31

g/l

0.40

165

Benign neoplasm: Liver

1.94

0.84

1.0

1.1

0.32

0.29

g/l

—

Ulcerative proctitis

1.63

0.84

1.1

0.35

0.29

g/l

—

Malignant neoplasm of prostate

226

0.73

0.84

1.3

0.33

0.31

g/l

0.38

179

Benign lipomatous neoplasm

362

1.27

0.83

1.4

1.2

0.31

g/l

0.03

298

Other cataract

383

1.23

0.83

1.1

1.3

0.32

0.31

g/l

0.79

316

Abscess of Bartholin gland

1.74

0.82

1.0

1.1

0.27

0.29

g/l

—

Other specified and unspecified disorders of eye and adnexa

1.74

0.82

1.1

1.2

0.31

0.29

g/l

—

Focal epilepsy

266

1.32

0.82

1.3

1.2

0.31

0.30

g/l

0.25

212

Granulomatous disorders of skin and subcutaneous tissue

1.88

0.82

1.5

1.1

0.33

0.30

g/l

—

Other other unspecified disorders of the circulatory system

1.88

0.82

1.0

1.2

0.33

0.28

g/l

—

Presence of cardiac and vascular implants and grafts

349

1.24

0.80

1.2

1.3

0.33

0.31

g/l

1.72

280

Other benign neoplasms of connective and other soft tissue

122

1.48

0.80

1.3

1.2

0.36

0.30

g/l

1.32

Alcohol dependence

338

1.27

0.79

1.1

1.2

0.34

0.30

g/l

2.59

276

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.79

0.0

1.2

—

0.29

—

Single delivery by caesarean section

266

1.24

0.79

1.1

1.2

0.29

0.30

g/l

0.48

210

Benign neoplasm: Liver/bile ducts

1.82

0.79

1.0

1.2

0.32

0.29

g/l

—

Other, unspecified and serous retinal detachments

0.00

0.79

0.0

1.2

—

0.28

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

1.1

—

0.30

—

Seropositive rheumatoid arthritis, wide

330

1.27

0.78

1.1

1.2

0.33

0.31

g/l

1.11

259

Graves ophthalmopathy, strict

0.00

0.77

0.0

1.1

—

0.28

—

Premature rupture of membranes

382

0.79

0.77

1.5

1.2

0.30

g/l

0.05

309

Insulin, fast-acting (human)

208

1.35

0.77

1.0

1.2

0.31

0.29

g/l

0.70

165

Other sexually transmitted chlamydial diseases

115

1.48

0.76

1.1

1.2

0.30

0.28

g/l

0.78

Abnormal findings on diagnostic imaging of central nervous system

1.70

0.76

1.3

1.1

0.31

0.29

g/l

—

Other abnormal uterine and vaginal bleeding

223

1.28

0.75

1.3

1.2

0.29

0.30

g/l

0.25

180

Papillary adenocarcinoma of thyroid gland

1.65

0.75

1.0

1.1

0.31

0.30

g/l

0.23

Foreign body in respiratory tract

1.65

0.75

1.2

1.1

0.30

0.29

g/l

0.12

Presence of other devices

209

1.34

0.75

1.3

1.2

0.32

0.30

g/l

0.76

163

Pre-eclampsia or poor fetal growth

650

1.18

0.73

1.2

0.31

0.30

g/l

0.67

524

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

133

1.43

0.73

1.2

1.3

0.31

0.30

g/l

0.13

103

Cholecystitis

133

1.43

0.73

1.3

1.2

0.28

0.30

g/l

0.63

102

In situ neoplasms

421

1.22

0.73

1.2

0.31

g/l

0.32

340

Nontraumatic intracranial haemmorrhage

167

1.38

0.73

1.5

1.2

0.30

0.31

g/l

0.32

128

Calculus of kidney and ureter

352

1.25

0.72

1.5

1.2

0.29

0.30

g/l

0.33

280

Organic, including symptomatic, mental disorders

339

0.79

0.72

1.2

1.3

0.31

g/l

0.14

271

Other predominantly sexually transmitted diseases, not elsewhere classified

299

1.27

0.72

1.3

0.27

0.29

g/l

0.81

243

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1.55

0.71

1.3

1.2

0.29

0.32

g/l

—

Dependent personality disorder

1.93

0.70

1.2

1.1

0.28

g/l

—

Cardiomyopathy

160

1.38

0.70

1.4

1.2

0.30

g/l

0.09

127

Hypoparathyroidism

1.71

0.70

1.3

1.1

0.32

0.30

g/l

—

Heart failure,strict

385

1.20

0.69

1.2

1.3

0.33

0.31

g/l

1.79

308

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1.55

0.69

1.4

1.2

0.36

0.31

g/l

—

Use of levodopa decarboxylase inhibitor

1.51

0.69

1.3

0.31

g/l

—

Lesion of sciatic nerve

1.85

0.68

1.4

1.1

0.28

0.30

g/l

—

Astigmatism

1.56

0.68

1.5

1.2

0.29

g/l

—

Hyperplasia of prostate

211

1.24

0.68

1.1

1.3

0.30

0.32

g/l

0.97

170

Medicines for HER+ breast cancer

471

1.20

0.66

1.2

0.33

0.31

g/l

1.26

382

Chalazion

136

1.40

0.66

1.4

1.2

0.28

0.29

g/l

0.22

112

Autonomic disorders

1.79

0.66

1.2

1.3

0.29

0.27

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

125

903

1.13

0.66

1.2

0.30

g/l

0.06

710

Diabetes mellitus in pregnancy

516

1.16

0.66

1.1

1.2

0.31

0.29

g/l

0.81

406

False labour

488

1.16

0.66

1.2

0.28

0.30

g/l

1.57

390

Hypermetropia

1.51

0.66

1.2

0.32

0.29

g/l

—

Coronary artery bypass grafting

169

1.31

0.65

1.3

0.31

g/l

0.06

137

Other juvenile arthritis

1.62

0.65

1.0

1.2

0.32

0.28

g/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

322

1.24

0.64

1.1

1.2

0.33

0.31

g/l

1.48

254

Mumps

1.73

0.64

1.4

1.2

0.35

0.28

g/l

—

Mixed hyperlipidaemia

1.73

0.64

1.2

0.34

0.28

g/l

—

Acute appendicitis, with complications

251

1.28

0.63

1.3

1.2

0.30

0.31

g/l

0.03

203

In situ neoplasms

451

1.20

0.62

1.2

0.31

g/l

0.22

363

malignant neoplasm of male genital organs

236

0.78

0.62

1.3

0.34

0.31

g/l

0.52

188

Other disorders of amniotic fluid and membranes

312

1.24

0.62

1.2

0.30

g/l

0.23

255

Diabetic retinopathy, excluding more controls

196

1.24

0.62

1.2

0.34

0.32

g/l

0.99

156

Viral agents as the cause of diseases classified to other chapters

1.67

0.61

1.0

1.1

0.32

0.31

g/l

—

Mixed disorders of conduct and emotions, excluding more controls

1.67

0.61

1.2

1.1

0.30

0.29

g/l

—

Chorioretinal inflammation

1.67

0.61

1.2

1.1

0.31

0.29

g/l

—

Other abnormal auditory perceptions

0.00

0.60

0.0

1.1

—

0.30

—

LSIL lesion of the vagina

0.00

0.60

0.0

1.1

—

0.30

—

Other localized connective tissue disorders

0.00

0.60

0.0

1.2

—

0.28

—

Toxic effect of other and unspecified substances

0.00

0.59

0.0

1.1

—

0.30

—

Malignant neoplasm of cervix uteri

0.00

0.59

0.0

1.2

—

0.30

—

Helminthiases

0.00

0.59

0.0

1.1

—

0.30

—

Benign neoplasm of other and unspecified female genital organs

1.54

0.59

1.0

1.2

0.30

0.31

g/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

518

0.86

0.59

1.2

0.32

0.31

g/l

0.36

413

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

518

0.86

0.59

1.2

0.32

0.31

g/l

0.36

413

Alzheimer’s disease (Early onset)

0.00

0.59

0.0

1.2

—

0.29

—

Unspecified mental disorder

676

1.15

0.59

1.1

1.2

0.33

0.30

g/l

3.00

540

Other/unspecified seropositive rheumatoid arthritis

326

1.23

0.59

1.1

1.2

0.33

0.31

g/l

1.47

257

Open wound of head

666

1.15

0.59

1.2

0.33

0.31

g/l

2.55

530

Female genital prolapse

255

1.20

0.59

1.3

1.2

0.30

0.31

g/l

0.24

202

Obstructed labour due to maternal pelvic abnormality

237

1.27

0.58

1.3

1.2

0.32

0.31

g/l

0.30

196

Artificial opening status

1.48

0.57

2.0

1.1

0.34

0.29

g/l

—

Benign neoplasm: Liver/bile ducts

1.67

0.56

1.0

1.1

0.32

0.29

g/l

—

Dental caries 1 and operation codes, only avohilmo

269

1.18

0.56

1.2

1.3

0.28

0.30

g/l

1.67

209

Benign lipomatous neoplasm

383

1.20

0.56

1.4

1.2

0.31

g/l

0.07

305

Urolithiasis

383

1.20

0.56

1.5

1.3

0.29

0.31

g/l

0.40

304

Leiomyoma of uterus

565

0.88

0.56

1.2

0.31

0.30

g/l

0.42

446

Benign neoplasm of other and unspecified female genital organs

1.46

0.56

1.0

1.1

0.30

g/l

—

Other aneurysm

1.62

0.55

1.2

0.34

0.29

g/l

—

Parkinson's disease, including avohilmo

107

1.40

0.55

1.2

1.3

0.35

0.30

g/l

—

All-cause Heart Failure

422

1.16

0.55

1.2

0.33

0.31

g/l

1.67

338

HSIL lesion of the cervix uteri, vagina or vulva

403

1.19

0.54

1.2

0.28

0.30

g/l

0.87

328

Maternal care for known or suspected abnormality of pelvic organs

424

1.16

0.54

1.2

0.31

0.30

g/l

0.36

338

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

178

0.77

0.54

1.2

1.3

0.33

0.31

g/l

0.57

143

Myopia

213

1.27

0.53

1.3

1.2

0.33

0.29

g/l

1.71

175

Parkinson's disease, strict definition, excluding more controls

1.43

0.53

1.2

1.3

0.34

0.32

g/l

—

Congenital deformities of feet

1.54

0.53

1.2

0.29

g/l

—

Varicose veins

100

673

1.12

0.51

1.2

0.30

0.31

g/l

0.50

540

Fracture of skull and facial bones

260

1.23

0.51

1.5

1.3

0.30

g/l

0.11

208

Focal epilepsy, strict definition

242

1.24

0.50

1.4

1.2

0.31

0.30

g/l

0.36

193

Valvular heart disease excluding rheumatic fever

413

0.85

0.50

1.3

1.2

0.33

0.31

g/l

0.84

334

Primary ovarian failure

1.47

0.50

1.7

1.1

0.37

0.29

g/l

—

Leiomyoma of uterus

109

690

0.90

0.49

1.3

1.2

0.32

0.31

g/l

0.61

542

Malignant neoplasm of breast, HER-positive

439

1.17

0.49

1.2

0.32

0.31

g/l

0.56

358

Agoraphobia

1.52

0.48

1.0

1.2

0.35

0.28

g/l

—

Streptococcal septicaemia

1.45

0.48

1.0

1.3

0.36

0.29

g/l

1.58

Parkinson's disease, excluding more controls

1.38

0.48

1.2

1.4

0.34

0.32

g/l

—

HSIL lesion of the cervix uteri

382

1.18

0.47

1.2

0.28

0.30

g/l

1.12

312

Other noninflammatory disorders of uterus, except cervix

191

1.22

0.46

1.1

1.2

0.31

g/l

0.05

151

Dental caries 3 and operation codes, only avohilmo

322

1.14

0.46

1.3

0.28

0.30

g/l

1.05

252

Major coronary heart disease event

555

1.12

0.46

1.2

0.33

0.31

g/l

0.71

454

Malignant neoplasm

153

987

0.92

0.45

1.3

1.2

0.31

g/l

0.08

127

781

Fitting and adjustment of other devices

323

1.18

0.44

1.3

0.31

g/l

0.08

258

Non-rheumatic valve diseases

407

0.86

0.44

1.3

1.2

0.33

0.31

g/l

0.81

328

Persons with potential health hazards related to communicable diseases

745

1.12

0.44

1.2

0.31

0.30

g/l

1.03

612

Disorders of speech understanding and production

1.38

0.44

1.0

1.2

0.28

0.29

g/l

—

Molar incisor enamel hypoplasia

1.37

0.44

1.4

1.1

0.29

0.31

g/l

—

Heart failure, strict

431

1.14

0.44

1.2

0.33

0.31

g/l

1.71

344

Supervision of normal pregnancy

299

1.15

0.43

1.2

0.29

0.30

g/l

1.28

243

Contact with and exposure to communicable diseases

637

1.13

0.43

1.2

0.31

0.29

g/l

0.87

526

Other diseases of spinal cord

1.62

0.43

1.0

1.2

0.36

0.27

g/l

—

Injuries to the elbow and forearm

129

1069

1.09

0.42

1.2

0.31

0.30

g/l

0.30

106

861

Dislocation, sprain and strain of joint and ligaments of hip

1.56

0.42

1.0

1.1

0.36

0.29

g/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.41

0.42

1.0

1.2

0.31

0.29

g/l

—

Malignant neoplasm of mesothelium and soft tissue

1.52

0.41

1.4

1.1

0.32

0.29

g/l

—

Other pulmonary heart/vessel disease

1.52

0.41

1.2

0.32

0.31

g/l

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

0.41

0.0

1.3

—

0.26

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

187

0.82

0.41

1.2

1.3

0.33

0.31

g/l

0.60

151

Parkinson's disease

105

1.33

0.41

1.2

1.3

0.34

0.31

g/l

—

1.47

0.40

1.2

1.1

0.32

0.29

g/l

—

Major anomalies of jaw size

1.47

0.40

1.2

0.31

0.29

g/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.00

0.40

0.0

1.1

—

0.27

—

Long labour

446

1.14

0.40

1.1

1.2

0.29

0.30

g/l

0.46

349

Chondromalacia

1.43

0.39

1.2

1.1

0.31

0.30

g/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

115

619

1.09

0.39

1.3

1.2

0.29

0.30

g/l

1.80

500

Bacterial meningitis

1.43

0.39

1.6

1.1

0.33

0.29

g/l

—

Maternal care for known or suspected malpresentation of fetus

339

1.14

0.39

1.2

0.31

0.30

g/l

0.50

272

Complications of internal orthopaedic prosthetic devices, implants and grafts

196

1.23

0.39

1.1

1.3

0.31

g/l

0.01

154

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

142

1.27

0.38

1.2

0.33

0.29

g/l

1.16

116

Other degenerative diseases of the nervous system

204

1.19

0.38

1.1

1.3

0.35

0.31

g/l

1.59

159

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

270

1.19

0.38

1.1

1.2

0.31

0.29

g/l

0.93

215

Gestational diabetes (for exclusion)

100

645

1.10

0.38

1.1

1.2

0.31

0.30

g/l

1.38

509

Congenital malformations of eye, ear, face and neck

1.33

0.37

1.5

1.2

0.28

0.29

g/l

—

Myocardial infarction, with ST-elevation

134

1.27

0.36

1.3

1.2

0.32

0.31

g/l

0.30

102

Strabismus

411

1.14

0.36

1.2

0.33

0.30

g/l

1.56

334

Congenital malformations of the circulatory system

201

1.21

0.35

1.2

0.30

0.29

g/l

0.12

161

Malignant neoplasm of breast, HER2-negative

563

0.90

0.35

1.2

0.32

0.31

g/l

0.28

450

Any event in cancer register

171

1083

0.94

0.35

1.3

1.2

0.31

g/l

0.37

138

860

Malignant neoplasm of breast

575

0.90

0.35

1.2

0.31

g/l

0.07

460

Inguinal hernia

534

1.10

0.35

1.2

0.31

0.30

g/l

0.54

426

Lesion of lateral popliteal nerve

1.33

0.33

1.0

1.1

0.36

0.29

g/l

—

Parkinson's disease, strict definition

100

1.30

0.33

1.2

1.3

0.34

0.30

g/l

—

Later onset COPD

150

1.20

0.32

1.2

0.33

0.32

g/l

0.13

115

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

1.35

0.32

1.2

0.31

g/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

384

1.12

0.31

1.2

0.32

0.31

g/l

0.64

313

Ectopic pregnancy

295

1.15

0.31

1.2

0.30

0.31

g/l

0.12

242

Postpartum haemorrhage

479

1.11

0.31

1.2

0.29

0.30

g/l

1.25

374

Osteoporosis

219

1.18

0.31

1.1

1.2

0.34

0.32

g/l

0.44

178

Complications of labour and delivery

137

714

1.07

0.30

1.3

1.2

0.29

0.31

g/l

1.77

110

562

Abnormal findings in secretions and smears from cervix uteri vagina vulva

112

819

1.07

0.29

1.2

0.30

g/l

0.11

645

Labour and delivery complicated by fetal stress [distress]

393

0.90

0.29

1.2

0.29

0.30

g/l

0.38

304

Infectious mononucleosis

148

1.22

0.29

1.1

1.2

0.24

0.28

g/l

—

117

Single spontaneous delivery

414

0.91

0.29

1.2

0.30

0.31

g/l

0.47

332

Erosion of teeth, including avohilmo

315

1.13

0.28

1.0

1.3

0.29

0.30

g/l

0.08

246

Heart failure and bmi 25plus

251

1.13

0.27

1.2

1.3

0.35

0.30

g/l

2.65

196

Schizophrenia or delusion, excluding more controls

419

1.11

0.27

1.1

1.3

0.32

0.30

g/l

2.20

342

Malignant melanoma, excluding all cancers (controls excluding all cancers)

168

1.19

0.27

1.2

0.34

0.31

g/l

0.60

135

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

243

1.15

0.26

1.1

1.2

0.31

0.30

g/l

0.48

192

Congenital malformations of heart and great arteries

181

1.18

0.26

1.1

1.2

0.29

g/l

0.19

149

Other complications of labour and delivery, not elsewhere classified

257

0.86

0.25

1.1

1.2

0.28

0.29

g/l

0.31

206

Purpura and other haemorrhagic conditions

160

1.19

0.25

1.2

1.3

0.33

0.30

g/l

0.74

130

Coronary revascularization (ANGIO or CABG)

329

1.10

0.25

1.3

0.32

g/l

0.14

266

Maternal care for other known or suspected fetal problems

414

1.08

0.24

1.2

0.30

g/l

0.01

331

Other diseases of biliary tract

1.28

0.24

1.1

1.2

0.35

0.30

g/l

—

Fracture of forearm

789

1.07

0.23

1.3

1.2

0.31

g/l

0.27

644

Mixed disorders of conduct and emotions

1.28

0.23

1.2

0.30

0.29

g/l

—

Ulcerative colitis (strict definition, require KELA)

247

1.13

0.22

1.1

1.2

0.31

0.30

g/l

0.48

195

Venous complications and haemorrhoids in pregnancy

1.22

0.22

1.4

1.2

0.30

0.29

g/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.22

0.22

1.0

1.1

0.33

0.28

g/l

—

Laparoscopic right hemicolectomy

1.22

0.22

1.0

1.2

0.33

0.29

g/l

—

Carcinoma in situ of cervix uteri

178

0.84

0.22

1.1

1.2

0.28

0.29

g/l

—

140

Carcinoma in situ of cervix uteri

178

0.84

0.22

1.1

1.2

0.28

0.29

g/l

—

143

Other assisted single delivery

1.19

0.21

1.0

1.2

0.29

0.30

g/l

—

Birth asphyxia

0.00

0.21

0.0

1.3

—

0.30

—

Puerperal sepsis

182

1.15

0.21

1.5

1.2

0.31

g/l

0.03

147

Malignant neoplasm of bone and articular cartilage

0.00

0.21

0.0

1.2

—

0.30

—

Calculus of lower urinary tract

1.16

0.21

1.4

1.2

0.28

0.30

g/l

—

Cleft lip and palate

0.00

0.21

0.0

1.1

—

0.30

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

0.21

0.0

1.2

—

0.32

—

Primary coxarthrosis, bilateral

249

1.12

0.20

1.1

1.3

0.32

g/l

0.20

203

Caries in Clefts patients

0.00

0.20

0.0

1.1

—

0.29

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

271

0.89

0.20

1.2

0.28

0.31

g/l

0.94

224

Malignant neoplasm of ovary

1.25

0.20

1.3

1.2

0.30

g/l

—

Tuberculosis, IBD comorbidity

1.25

0.20

1.0

1.1

0.33

0.30

g/l

—

Cardiac arrest

1.23

0.20

1.3

1.2

0.29

0.30

g/l

—

Diabetic retinopathy

278

1.09

0.20

1.3

1.2

0.33

0.32

g/l

0.35

220

Scabies

1.15

0.19

1.2

0.32

0.29

g/l

—

Antepartum haemorrhage, not elsewhere classified

196

0.87

0.18

1.0

1.2

0.32

0.29

g/l

0.79

158

Glaucoma

559

1.07

0.18

1.2

0.33

0.31

g/l

0.80

449

Caught, crushed, jammed or pinched in or between objects

1.21

0.18

1.3

1.2

0.31

0.30

g/l

—

Calcific aortic valvular stenosis

212

0.88

0.18

1.2

1.3

0.37

0.32

g/l

1.32

162

Calcific aortic valvular stenosis, operated

212

0.88

0.18

1.2

1.3

0.37

0.32

g/l

1.32

162

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

372

0.92

0.18

1.5

1.2

0.32

0.31

g/l

0.17

301

Meningitis

1.15

0.17

1.4

1.1

0.32

0.30

g/l

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

416

1.08

0.17

1.2

0.34

0.31

g/l

1.35

339

Postpartum hemorraghe, parous women as controls

500

1.07

0.17

1.2

0.29

0.30

g/l

0.66

395

Fall on and from ladder

0.72

0.17

1.0

1.2

0.29

0.30

g/l

—

Distal bite

1.14

0.16

1.4

1.2

0.29

g/l

—

Poor fetal growth

277

0.90

0.16

1.2

0.33

0.29

g/l

1.16

229

Maternal care for known or suspected fetal abnormality and damage

338

0.92

0.15

1.1

1.2

0.28

0.30

g/l

0.82

278

Calcific aortic valvular stenosis, including rheumatic fever

209

0.89

0.15

1.2

1.3

0.37

0.31

g/l

1.39

160

Conductive and sensorineural hearing loss

120

797

1.04

0.15

1.2

0.30

0.31

g/l

0.29

645

Operations 2 for CAVS

209

0.89

0.15

1.2

1.3

0.37

0.31

g/l

1.39

160

Calcific aortic valvular stenosis, diagnosis (helper)

209

0.89

0.15

1.2

1.3

0.37

0.31

g/l

1.39

160

Coronary angioplasty

277

1.08

0.15

1.3

0.32

g/l

0.16

222

Secondary and unspecified malignant neoplasm of lymph nodes

1.10

0.15

1.2

0.34

0.30

g/l

—

Cardiodefibrillation

337

0.92

0.15

1.5

1.2

0.31

g/l

0.14

266

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

381

0.94

0.14

1.3

1.2

0.31

g/l

0.06

311

Other disorders of cornea

103

1.17

0.13

1.1

1.2

0.30

g/l

—

Other strabismus

354

1.07

0.12

1.2

0.34

0.30

g/l

1.44

288

Emergency coronary revascularization (for ACS)

381

1.06

0.12

1.3

0.32

g/l

0.10

304

Malignant neoplasm of skin

520

0.96

0.11

1.3

0.31

g/l

0.23

423

Sulfonylureas

230

1.08

0.11

1.1

1.3

0.35

0.31

g/l

1.71

179

All dysplastic lesions of the cervix uteri

562

1.05

0.10

1.2

0.28

0.30

g/l

0.90

454

Ulcerative colitis (strict definition, all Crohn cases excluded)

202

1.09

0.10

1.0

1.2

0.30

0.29

g/l

0.10

160

Carcinoma in situ of skin of other and unspecified parts of face

1.14

0.10

1.4

1.2

0.31

0.32

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1.13

0.10

1.6

1.2

0.34

0.31

g/l

—

Coxarthrosis, primary

587

0.96

0.09

1.1

1.2

0.31

g/l

0.01

477

Secondary uncertain malignant neoplasm

116

1.12

0.09

1.2

0.34

0.30

g/l

1.48

Postpartum hemorraghe, all women as controls

583

1.04

0.09

1.2

0.29

0.30

g/l

0.71

474

Hypoplasia of dental enamel , including avohilmo

1.03

0.09

1.0

1.2

0.32

0.30

g/l

—

Primary open-angle glaucoma, strict

213

1.08

0.09

1.3

0.36

0.31

g/l

1.47

166

Tuberculosis, wide

1.09

0.08

1.0

1.2

0.33

0.30

g/l

—

Scissor bite

1.09

0.08

1.2

0.28

g/l

—

Postpartum haemorrhage due to anatomy

214

1.08

0.08

1.3

1.2

0.27

0.29

g/l

1.15

172

All dysplastic lesions of the cervix uteri, vagina or vulva

614

1.04

0.08

1.2

0.29

0.30

g/l

0.75

487

Other malignant neoplasms of skin (=non-melanoma skin cancer)

443

0.96

0.07

1.4

1.3

0.31

g/l

0.11

359

Pediculosis, acariasis and other infestations

0.84

0.07

1.2

0.32

0.29

g/l

—

Retained placenta and membranes, without haemorrhage

196

1.07

0.07

1.3

1.2

0.30

0.31

g/l

0.25

160

Multiple delivery

163

0.92

0.07

1.1

1.3

0.32

0.31

g/l

0.13

126

Delivery, wide proxy

340

1.03

0.06

1.2

0.30

0.31

g/l

0.62

274

Abnormal findings on antenatal screening of mother

178

1.07

0.05

1.2

1.3

0.27

0.29

g/l

0.34

146

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

369

0.97

0.04

1.3

1.2

0.31

g/l

0.06

303

Degenerative diseases of the nervous system

172

1.05

0.04

1.0

1.3

0.33

0.32

g/l

0.17

132

Parodontitis or/and operation codes

130

761

1.02

0.04

1.1

1.2

0.33

0.30

g/l

3.76

100

599

Kela-code for severe mental illness

584

0.98

0.04

1.2

0.34

0.30

g/l

2.56

469

LSIL lesion of the cervix uteri, vagina or vulva

271

0.96

0.04

1.2

0.30

0.29

g/l

0.10

218

Delivery

415

0.98

0.03

1.2

0.30

0.31

g/l

0.63

333

Coxarthrosis, primary, with hip surgery

428

0.97

0.03

1.1

1.3

0.30

0.31

g/l

0.36

348

Basal cell carcinoma

453

1.02

0.03

1.3

0.31

g/l

0.01

366

Other and unspecified nonorganic psychotic disorders

291

1.03

0.02

1.2

0.32

0.29

g/l

1.40

239

Primary open-angle glaucoma

255

1.03

0.02

1.2

0.35

0.32

g/l

1.23

202

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

398

1.02

0.02

1.3

1.2

0.31

g/l

0.12

325

Basal cell carcinoma, including avohilmo

463

0.99

0.01

1.3

0.31

g/l

0.03

375

Malignant neoplasm, wide definition for exclusion

168

998

0.99

0.01

1.3

1.2

0.31

g/l

0.33

135

792

Antenatal screening

306

1.01

0.00

1.2

0.28

0.30

g/l

1.49

247

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

168

997

1.00

0.00

1.3

1.2

0.31

g/l

0.33

135

791

Glucosamine medication

418

1.01

0.00

1.3

1.2

0.30

0.32

g/l

0.55

335

Sensorineural hearing loss

103

725

0.99

0.00

1.2

0.30

0.31

g/l

0.40

585

Schizophrenia, schizotypal and delusional disorders

476

1.01

0.00

1.1

1.2

0.33

0.30

g/l

2.10

379

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

466

1.00

0.00

1.2

0.31

g/l

0.08

381

Schizophrenia or delusion

474

0.99

0.00

1.1

1.2

0.32

0.30

g/l

1.84

377

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

146

1.03

0.00

1.2

0.33

0.31

g/l

0.48

114

LSIL lesion of the cervix uteri

216

1.02

0.00

1.1

1.2

0.29

g/l

0.01

175

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

169

997

1.00

0.00

1.3

1.2

0.31

g/l

0.36

136

791

Left ventricular outflow tract obstruction (LVOTO), broad definition

121

0.99

0.00

1.3

1.2

0.31

0.30

g/l

—

102

Unspecified protein-energy malnutrition

0.00

0.0

1.2

—

0.34

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.2

—

0.29

—

Exposure to excessive natural cold

0.00

0.0

1.1

—

0.29

—

Marasmic kwashiorkor

0.00

0.0

1.2

—

0.28

—

Meningitis, viral

0.00

0.0

1.2

—

0.32

—

Burn and corrosion of other internal organs

0.00

0.0

1.0

—

0.29

—

Tympanosclerosis

0.00

0.0

1.0

—

0.30

—

Unspecified severe protein-energy malnutrition

0.00

0.0

1.0

—

0.37

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.2

—

0.27

—

Atrioventricular septal defect

0.00

0.0

1.2

—

0.29

—

Turner's syndrome

0.00

0.0

1.1

—

0.28

—

Adenocarcinomas of cervix

0.00

0.0

1.3

—

0.30

—

Unspecified transport accident

0.00

0.0

1.1

—

0.31

—

Cardiovascular disorders originating in the perinatal period

0.00

0.0

1.3

—

0.30

—

Familial erythrocytosis

0.00

0.0

1.2

—

0.30

—

Juvenile Open Angle Glaucoma

0.00

0.0

1.2

—

0.31

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.0

—

0.28

—

Reduction defects of upper limb

0.00

0.0

1.0

—

0.37

—

Acne conglobata

0.00

0.0

1.0

—

0.30

—

Other abnormal findings of blood chemistry

0.88

0.00

1.4

1.1

0.37

0.29

g/l

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.0

1.2

—

0.29

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.0

1.0

—

0.30

—

Respiratory tuberculosis, clinically confirmed

0.00

0.0

1.2

—

0.32

—

Persistent delusional disorders

0.90

0.00

1.4

1.1

0.30

g/l

—

Other disorders of optic [2nd] nerve and visual pathways

0.92

0.00

1.4

1.2

0.30

0.29

g/l

—

Injury of nerves at hip and thigh level

0.00

0.0

1.2

—

0.34

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.0

—

0.34

—

Burns classified according to extent of body surface involved

0.00

0.0

1.0

—

0.32

—

Epidural haemorrhage

0.00

0.0

1.2

—

0.30

—

Impaction of intestines

0.00

0.0

1.1

—

0.27

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.0

1.2

—

0.33

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.0

1.2

—

0.34

—

Frostbite with tissue necrosis

0.00

0.0

1.0

—

0.31

—

Chronic thyroiditis

0.00

0.0

1.0

—

0.30

—

Contact with sharp glass

1.02

0.00

3.0

1.1

0.33

0.28

g/l

—

Delirium, not induced by alcohol and other psychoactive substances

0.88

0.00

1.1

1.3

0.30

g/l

—

ILD medications: nintedanib

0.00

0.0

1.2

—

0.27

—

Osteitis due to dental implant

0.00

0.0

1.2

—

0.33

—

Thyrotoxicosis factitia

0.00

0.0

1.2

—

0.30

—

Idiopathic peripheral autonomic neuropathy

0.00

0.0

1.2

—

0.34

—

Food allergy

0.00

0.0

1.0

—

0.29

—

Sequelae of burns, corrosions and frostbite

0.00

0.0

1.0

—

0.33

—

Other conditions of integument specific to fetus and newborn

0.00

0.0

1.0

—

0.26

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.0

1.0

—

0.33

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.0

—

0.32

—

Polyglandular dysfunction

0.00

0.0

1.0

—

0.31

—

Glaucoma secondary to eye inflammation

0.00

0.0

1.1

—

0.30

—

Other and unspecified iridocyclitis

1.02

0.00

1.0

1.1

0.30

0.29

g/l

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.0

1.0

—

0.30

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.0

1.2

—

0.29

—

Benign neoplasm: Pineal gland

0.00

0.0

1.0

—

0.28

—

Rheumatic fever with heart involvement

0.00

0.0

1.0

—

0.35

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.1

—

0.31

—

Acquired absence of limb

0.00

0.0

1.2

—

0.30

—

Labyrinthitis

0.00

0.0

1.0

—

0.33

—

Intercostal neuropathy

0.00

0.0

1.2

—

0.30

—

Transient retinal artery occlusion

0.00

0.0

1.0

—

0.31

—

Brain astrocytoma

0.00

0.0

1.0

—

0.29

—

Carcinoma in situ of endometrium

0.00

0.0

1.2

—

0.33

—

Benign neoplasm: Carotid body

0.00

0.0

1.0

—

0.33

—

Defect, injury or illness of lumbar spine

0.00

0.0

1.0

—

0.35

—

Hookworm diseases

0.00

0.0

1.0

—

0.31

—

Aphakia

0.00

0.0

1.3

—

0.32

—

Hereditary spherocytosis

0.00

0.0

1.0

—

0.33

—

Immunodeficiency associated with other major defects

0.00

0.0

1.0

—

0.32

—

Cytomegaloviral hepatitis

0.00

0.0

1.2

—

0.30

—

Disorder of mineral metabolism, other/unspecified

0.00

0.0

1.0

—

0.31

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

0.30

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.0

1.1

—

0.28

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

0.0

1.0

—

0.30

—

Maxillary hypoplasia

0.00

0.0

1.0

—

0.32

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.0

1.0

—

0.34

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.0

—

0.31

—

Disorders of muscle tone of newborn

0.00

0.0

1.0

—

0.27

—

Acrodermatitis continua

0.00

0.0

1.0

—

0.32

—

Birth injury to skeleton

0.00

0.0

1.0

—

0.35

—

Benign neoplasm: Lower jaw bone

0.00

0.0

1.2

—

0.33

—

Rheumatoid lung disease

0.00

0.0

1.0

—

0.33

—

Other disorders of bone development and growth

0.00

0.0

1.0

—

0.32

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

1.0

—

0.29

—

Thiamine deficiency

0.00

0.0

1.3

—

0.31

—

Other hypertrichosis

0.00

0.0

1.1

—

0.26

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.0

—

0.32

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.0

1.0

—

0.32

—

Localized adiposity

0.00

0.0

1.3

—

0.29

—

Complications of anaesthesia during labour and delivery

0.00

0.0

1.1

—

0.31

—

Neonatal aspiration syndromes

0.00

0.0

1.0

—

0.27

—

Haemolytic disease of fetus and newborn

0.00

0.0

1.6

—

0.27

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.0

1.0

—

0.36

—

Congenital malformations of oesophagus

0.00

0.0

1.0

—

0.32

—

Burn and corrosion of wrist and hand

0.93

0.00

1.6

1.2

0.24

0.29

g/l

—

Other specified transport accidents

0.00

0.0

1.0

—

0.30

—

Mantle cell lymphoma

0.00

0.0

1.0

—

0.32

—

Café au lait spots

0.00

0.0

1.0

—

0.31

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.0

1.2

—

0.28

—

Metabolic disorder, other/unspecified

0.00

0.0

1.1

—

0.30

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

0.33

—

Glaucoma, exfoliation

0.95

0.00

1.3

0.37

0.32

g/l

—

Osteogenesis imperfecta

0.00

0.0

1.0

—

0.36

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.0

1.2

—

0.33

—

Tuberous sclerosis 1

0.00

0.0

1.2

—

0.28

—

Acromegaly and pituitary gigantism

0.00

0.0

1.1

—

0.31

—

Carcinoma in situ of skin of other and unspecified parts of face

0.98

0.00

1.4

1.2

0.31

0.32

g/l

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.2

—

0.33

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.0

1.0

—

0.31

—

Sequelae of tuberculosis

0.00

0.0

1.3

—

0.31

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.2

—

0.29

—

Nosocomial condition (hospital)

0.00

-0.00

0.0

1.0

—

0.31

—

Other hereditary haemolytic anaemias

0.00

-0.00

0.0

1.0

—

0.34

—

Contact with other and unspecified heat and hot substances

0.00

-0.00

0.0

1.0

—

0.27

—

Deaf mutism, not elsewhere classified

0.00

-0.00

0.0

1.0

—

0.33

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS